Data / Research funding / Diabetes
Diabetes: 3,863 NIH awards ($5.2B) to 527 organizations
3,863 NIH awards ($5.2B) in the NIH spending category Diabetes, to 527 organizations, read 2026-11-04. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 3,863 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Immune Tolerance Network | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $203,912,588 | February 1, 2014 | January 31, 2028 | BUCKNER, JANE HOYT | reporter.nih.gov |
| Data Coordinating Center for Type 1 Diabetes TrialNet | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $99,686,705 | September 30, 2015 | May 31, 2030 | KRISCHER, JEFFREY P | reporter.nih.gov |
| Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young Study (TEDDY) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $73,059,202 | April 28, 2021 | December 31, 2026 | KRISCHER, JEFFREY P | reporter.nih.gov |
| Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project | NIH | National Institute on Aging | 2022 to 2025 | $66,521,567 | September 1, 2022 | August 31, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| DRCR Retina Network | NIH | National Eye Institute | 2021 to 2025 | $43,226,123 | September 30, 2002 | December 31, 2028 | GLASSMAN, ADAM R | reporter.nih.gov |
| Human Pancreas Analysis Program for Type 1 Diabetes - HPAP-T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $37,867,556 | September 20, 2016 | June 30, 2029 | NAJI, ALI | reporter.nih.gov |
| Epidemiology of Diabetes Interventions and Complications (EDIC) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $35,015,476 | September 22, 2011 | June 30, 2027 | GUBITOSI-KLUG, ROSE A | reporter.nih.gov |
| RhoFED CDSMC | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $28,374,518 | May 8, 2023 | April 30, 2028 | SCHMIDT, PETER N. | reporter.nih.gov |
| Southern California Center for Chronic Health Disparities in Latino Children and Families. | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $27,816,472 | September 24, 2021 | June 30, 2027 | GORAN, MICHAEL ISAAC | reporter.nih.gov |
| Bridge2AI: Salutogenesis Data Generation Project | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $24,700,328 | September 1, 2022 | August 31, 2026 | LEE, AARON | reporter.nih.gov |
| The Mid-Atlantic Center for Cardiometabolic Health (MACCH) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $24,163,298 | September 24, 2021 | June 30, 2027 | COOPER, LISA A | reporter.nih.gov |
| Follow-up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in The Environmental Determinants of Diabetes in The Young Study (TEDDY) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $19,999,721 | April 13, 2020 | March 31, 2024 | KRISCHER, JEFFREY P | reporter.nih.gov |
| Data Coordinating Center for the Type 1 Diabetes in Acute Pancreatitis Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $17,043,926 | September 17, 2020 | July 31, 2025 | CHINCHILLI, VERNON M | reporter.nih.gov |
| Diabetes and brain amyloid in middle aged Hispanics | NIH | National Institute on Aging | 2021 to 2025 | $16,383,484 | September 1, 2015 | May 31, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| Southeast Collaborative for Innovative Solutions to Chronic Diseases | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $15,450,960 | September 24, 2021 | June 30, 2027 | WILKINS, CONSUELO HOPKINS | reporter.nih.gov |
| Center for Cellular Metabolism Research in Oklahoma | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $15,159,612 | February 5, 2021 | January 31, 2027 | XIA, LIJUN | reporter.nih.gov |
| Integrated Islet Distribution Program (U24) - 2021 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $14,918,013 | September 30, 2012 | July 31, 2027 | NILAND, JOYCE CAROL | reporter.nih.gov |
| CODA: COvid and Diabetes Assessment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $14,508,027 | July 21, 2023 | June 30, 2028 | ROTHMAN, RUSSELL L. | reporter.nih.gov |
| Human Pancreas Analysis Program for Type 2 Diabetes (HPAP-T2D) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $14,146,004 | July 28, 2025 | December 31, 2028 | KAESTNER, KLAUS H | reporter.nih.gov |
| Environmental influences on Child Health Outcomes in the Northern Plains PASS-ECHO Cohort | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $13,912,786 | September 21, 2016 | May 31, 2030 | ELLIOTT, AMY J | reporter.nih.gov |
| University of Michigan Data Coordinating Center for the Diabetic Foot Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $13,554,809 | July 1, 2019 | December 31, 2027 | SPINO, CATHERINE A | reporter.nih.gov |
| Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $13,003,302 | July 8, 2022 | June 30, 2027 | MAAHS, DAVID MATTHEW | reporter.nih.gov |
| Environmental influences on Child Health Outcomes in the Northern Plains PASS-ECHO Cohort | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $12,584,157 | September 21, 2016 | May 31, 2025 | ELLIOTT, AMY J | reporter.nih.gov |
| California Partnership for Personalized Nutrition | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $11,224,088 | December 10, 2021 | November 30, 2026 | ADAMS, SEAN HARRISON | reporter.nih.gov |
| The DUST Center: Hazardous Dust in Drylands - Exposure, Health Impacts, and Mitigation | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $11,160,526 | April 1, 1997 | January 31, 2030 | DING, XINXIN | reporter.nih.gov |
| Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $10,900,445 | September 21, 2016 | May 31, 2030 | FERRARA, ASSIAMIRA | reporter.nih.gov |
| NYR-Diabetes Research Center (NYR-DRC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $10,878,379 | December 1, 1996 | April 30, 2030 | PESSIN, JEFFREY E. | reporter.nih.gov |
| Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $10,346,124 | September 25, 2012 | July 31, 2025 | KRAUSE-STEINRAUF, HEIDI | reporter.nih.gov |
| Kansas Center for Metabolism and Obesity REsearch (KC-MORE) | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $10,233,525 | April 1, 2022 | February 28, 2027 | WEINMAN, STEVEN A | reporter.nih.gov |
| RARE and Atypical Diabetes Network(RADIANT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $9,843,448 | September 10, 2018 | May 31, 2029 | BALASUBRAMANYAM, ASHOK | reporter.nih.gov |
| Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $9,439,774 | March 10, 2016 | June 30, 2027 | MILLS, KATHERINE TERESA | reporter.nih.gov |
| Center for Identification and Study of Individuals with Atypical Diabetes Mellitus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,233,898 | September 10, 2018 | May 31, 2029 | PHILIPSON, LOUIS H. | reporter.nih.gov |
| An Encyclopedia of the Adipose Tissue Secretome to Identify Mediators of Health and Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,233,323 | July 15, 2021 | June 30, 2026 | COHEN, PAUL | reporter.nih.gov |
| Glycemic Profile of Pregnancy Consortium Biostatistics Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,810,207 | September 20, 2019 | July 31, 2026 | SCHOLTENS, DENISE M | reporter.nih.gov |
| dkNET Coordinating Unit: Harnessing the Power of AI and Data Science forCollaborative Discovery and Sharing in the DK Community | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $8,645,871 | December 1, 2012 | February 28, 2029 | GRETHE, JEFFREY S. | reporter.nih.gov |
| Central Hub for Kidney Precision Medicine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $8,320,420 | July 1, 2024 | June 30, 2027 | HIMMELFARB, JONATHAN | reporter.nih.gov |
| Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes - Biostatistics Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $8,171,506 | April 1, 2023 | January 31, 2028 | BRAFFETT, BARBARA HALINA | reporter.nih.gov |
| KPMP Kidney Mapping and Atlas Project (KMAP) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,070,448 | September 20, 2022 | June 30, 2027 | KRETZLER, MATTHIAS | reporter.nih.gov |
| Bridge2AI:Salutogenesis Data Generation Project | NIH | Office of the Director, National Institutes of Health | 2025 | $7,981,760 | September 1, 2025 | November 30, 2026 | LEE, AARON | reporter.nih.gov |
| Indiana Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,959,091 | July 6, 2015 | May 31, 2030 | EVANS-MOLINA, CARMELLA | reporter.nih.gov |
| Diabetes Research Center (DRC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,913,084 | December 1, 2002 | June 30, 2028 | SALTIEL, ALAN R. | reporter.nih.gov |
| COBRE-DIABETES | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $7,892,762 | August 1, 2017 | April 30, 2029 | GERSCHENSON, MARIANA | reporter.nih.gov |
| Columbia Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,800,557 | September 1, 2002 | December 31, 2027 | PAJVANI, UTPAL | reporter.nih.gov |
| Renewal of the Human Islet Research Enhancement Center (HIREC) for the Type-1-Diabetes-Focused Human Islet Research Network (HIRN). | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,703,361 | September 15, 2014 | June 30, 2029 | KADDIS, JOHN S. | reporter.nih.gov |
| Look AHEAD Sleep: Sleep-disordered breathing, circadian rest/activity rhythms, and the risk of Alzheimer's disease and related dementias in Look AHEAD | NIH | National Institute on Aging | 2021 to 2025 | $7,592,411 | August 15, 2021 | May 31, 2027 | UDEH-MOMOH, CHINEDU THERESA | reporter.nih.gov |
| Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,571,345 | December 1, 1996 | December 31, 2027 | KAHN, STEVEN EMANUEL | reporter.nih.gov |
| The Biostatistics Research Center for the Impaired Awareness of Hypoglycemia Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $7,517,806 | September 25, 2022 | December 31, 2027 | CHINCHILLI, VERNON M | reporter.nih.gov |
| Bridging the gap between type 2 diabetes GWAS and therapeutic targets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $7,480,415 | August 20, 2020 | June 30, 2026 | MOHLKE, KAREN L. | reporter.nih.gov |
| Diabetes Research and Training Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,258,898 | December 1, 1996 | March 31, 2028 | MIRMIRA, RAGHAVENDRA G | reporter.nih.gov |
| Vanderbilt Integrated Center of Excellence in Maternal and Pediatric Precision Therapeutics (VICE-MPRINT) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $7,225,339 | September 10, 2021 | July 31, 2027 | KANNANKERIL, PRINCE JOSEPH | reporter.nih.gov |
| Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $7,099,019 | August 1, 2022 | May 31, 2027 | ATKINSON, MARK A. | reporter.nih.gov |
| Action for Health in Diabetes (Look AHEAD) Extended Follow-up (LA-E2) | NIH | National Institute on Aging | 2021 to 2025 | $7,064,037 | August 1, 2021 | July 31, 2027 | ESPELAND, MARK ANDREW | reporter.nih.gov |
| Functional Interrogation of T2D-associated genes in human stem cell-derived models and mice | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $6,998,766 | August 20, 2020 | June 30, 2025 | SEALE, PATRICK | reporter.nih.gov |
| North Carolina Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,742,732 | April 7, 2020 | May 31, 2028 | NEUFER, P DARRELL | reporter.nih.gov |
| UAB Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,482,639 | April 1, 2008 | May 31, 2028 | BASU, ANANDA | reporter.nih.gov |
| The impact of genomic variation on environment-induced changes in pancreatic beta cell states | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,348,795 | September 7, 2021 | May 31, 2027 | CARTER, HANNAH KATHRYN | reporter.nih.gov |
| Interferon Signaling in the T1D Islet Microenvironment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,240,105 | September 15, 2020 | August 31, 2029 | MIRMIRA, RAGHAVENDRA G | reporter.nih.gov |
| Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $6,206,632 | September 21, 2016 | May 31, 2025 | FERRARA, ASSIAMIRA | reporter.nih.gov |
| Metabolic effects and mechanisms for heart failure in South Asians | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,092,913 | June 7, 2021 | May 31, 2027 | KANAYA, ALKA M. | reporter.nih.gov |
| Georgia Center for Diabetes Translation Research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $5,974,308 | September 16, 2016 | July 31, 2026 | NARAYAN, KABAYAM M VENKAT | reporter.nih.gov |
| Study of Latinos (SOL) Ojos | NIH | National Eye Institute | 2021 to 2023 | $5,789,999 | September 1, 2019 | July 31, 2025 | JOSLIN, CHARLOTTE E | reporter.nih.gov |
| I-TRUST: Implementation of Teleophthalmology in Rural Health Systems Study | NIH | National Eye Institute | 2021 to 2025 | $5,785,363 | September 30, 2021 | August 31, 2027 | LIU, YAO | reporter.nih.gov |
| Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,660,048 | March 1, 2023 | February 29, 2028 | BRICKMAN, WENDY J | reporter.nih.gov |
| A multilevel community engaged intervention to build a sustainable and equitable food economy with food is medicine offerings in the Mississippi Delta to improve minority health and reduce disparities | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $5,583,400 | September 23, 2022 | May 31, 2027 | ECONOMOS, CHRISTINA D | reporter.nih.gov |
| Addressing Marshallese Immigrant Barriers to Diabetes Self-Management through Family DSMES | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2023 | $5,362,317 | July 29, 2019 | February 28, 2026 | MCELFISH, PEARL | reporter.nih.gov |
| Understanding Neurocognition in Youth with Type 1 Diabetes (UNYT1D) Biostatistics Research Center (BRC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $5,150,596 | August 15, 2024 | June 30, 2029 | HELGESON, ERIKA S. | reporter.nih.gov |
| Identifying new strategies for prevention of cardiovascular complications of diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,112,534 | May 1, 2020 | April 30, 2026 | BORNFELDT, KARIN E | reporter.nih.gov |
| Composite porcine islet-kidney xenotransplants to cure diabetes and renal failure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,035,116 | May 21, 2020 | April 30, 2026 | SACHS, DAVID H | reporter.nih.gov |
| Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,932,783 | September 10, 2019 | June 30, 2025 | ROBERTS, CHARLES T | reporter.nih.gov |
| Development of Polygenic Risk Scores for Diabetes and Complications across the Life-Span in Populations of Multiple Ancestries | NIH | National Human Genome Research Institute | 2021 to 2025 | $4,851,908 | June 8, 2021 | March 31, 2027 | MERCADER, JOSEP MARIA | reporter.nih.gov |
| Delineating mechanisms of skeletal fragility in older adults with Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,798,865 | February 1, 2021 | January 31, 2027 | YU, ELAINE WEI-YIN | reporter.nih.gov |
| Emory Specialized Center of Research Excellence (SCORE) on Sex Differences | NIH | National Institute on Aging | 2021 to 2025 | $4,701,718 | September 30, 2018 | July 31, 2030 | LAHIRI, CECILE DELILLE | reporter.nih.gov |
| The Mobility Opportunity Voucher to Eliminate Diabetes and obesity (MOVED) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $4,689,372 | February 15, 2023 | January 31, 2028 | POLLACK, CRAIG EVAN | reporter.nih.gov |
| Processed Food Intake, Metabolomics, and Adiposity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,680,142 | August 1, 2020 | June 30, 2025 | STEFFEN, LYN M | reporter.nih.gov |
| Microphysiological systems to interrogate the Islet-Liver-Adipose Axis in normal physiology and Type-2 Diabetes Mellitus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,582,323 | September 20, 2018 | July 31, 2024 | STAHL, ANDREAS | reporter.nih.gov |
| Addressing Social Determinants of Health to Improve Diabetes Prevention Program Outcomes Among Underserved African Americans | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $4,516,834 | April 1, 2020 | March 31, 2026 | BERKLEY-PATTON, JANNETTE YVONNE | reporter.nih.gov |
| Diabetes Endothelial Keratoplasty Study: Impact of Diabetes on Corneal Transplant Success and Cell Loss | NIH | National Eye Institute | 2021 to 2025 | $4,496,381 | May 1, 2021 | April 30, 2026 | GAL, ROBIN L | reporter.nih.gov |
| Early Pathogenesis of Cystic Fibrosis Related Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,452,977 | April 30, 2021 | March 31, 2024 | ENGELHARDT, JOHN F | reporter.nih.gov |
| Metformin in Pregnancy: Fetal Consequences & Long-term Offspring Outcomes in a NHP Model | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,424,392 | September 17, 2021 | July 31, 2024 | AAGAARD, KJERSTI MARIE | reporter.nih.gov |
| Diabetes and Related Metabolic Diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,400,146 | July 1, 1975 | June 30, 2030 | SEMENKOVICH, CLAY F. | reporter.nih.gov |
| Neonatal porcine islet xenografts for the treatment of type 1 diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,363,576 | September 1, 2010 | June 30, 2025 | KIRK, ALLAN D. | reporter.nih.gov |
| Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $4,324,679 | September 20, 2018 | July 31, 2023 | TAYLOR, D. LANSING | reporter.nih.gov |
| Neurobiological mechanisms of altered cortical plasticity in Type-2 diabetes mellitus | NIH | National Institute on Aging | 2021 to 2025 | $4,283,713 | March 1, 2021 | February 28, 2027 | FRIED, PETER J | reporter.nih.gov |
| Charting human islet maturation via combined soft nanoelectronics and single-cell spatial transcriptomics | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,276,659 | September 17, 2021 | May 31, 2027 | LIU, JIA | reporter.nih.gov |
| Subtyping COre for Research on the Etiology of Type 2 Diabetes (SCORE-T2D) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $4,227,177 | September 1, 2024 | August 31, 2029 | KECHRIS-MAYS, KATHERINA | reporter.nih.gov |
| Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno Peru (ANDES study) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $4,214,806 | September 30, 2020 | January 31, 2027 | HARTINGER, STELLA MARIA | reporter.nih.gov |
| Dissecting cell type-specific genetic programming of islet (dys)function in type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,048,491 | December 3, 2020 | November 30, 2028 | STITZEL, MICHAEL LEE | reporter.nih.gov |
| Diabetes Endothelial Keratoplasty Study(DEKS): Impact of Diabetes on Corneal Transplant Success and Cell Loss | NIH | National Eye Institute | 2021 to 2025 | $4,021,141 | May 1, 2021 | April 30, 2027 | LASS, JONATHAN H | reporter.nih.gov |
| Epitranscriptomics in human obesity and type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $4,016,560 | July 1, 2024 | June 30, 2029 | KULKARNI, ROHIT N. | reporter.nih.gov |
| Type 1 Diabetes TrialNet Clinical Network Hub | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,959,999 | September 9, 2014 | May 31, 2030 | GREENBAUM, CARLA J | reporter.nih.gov |
| Food Timing to Mitigate Adverse Consequences of Night Work | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,943,217 | July 1, 2021 | June 30, 2027 | SCHEER, FRANK A | reporter.nih.gov |
| Michigan Center for Diabetes Translational Research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,938,400 | September 6, 2011 | January 31, 2027 | HEISLER, MARY ELLEN MICHELE | reporter.nih.gov |
| Harnessing engineered T regulatory cells to promote beta cell health in T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,920,533 | April 8, 2022 | January 31, 2026 | BUCKNER, JANE HOYT | reporter.nih.gov |
| Diabetes Research and Engagement through Advanced Multilevel Science Center for Diabetes Translational Research (DREAMS-CDTR) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,905,698 | September 1, 2011 | June 30, 2027 | SCHMITTDIEL, JULIE A | reporter.nih.gov |
| The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes. | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,858,238 | January 1, 2021 | October 31, 2026 | NAVAS-ACIEN, ANA | reporter.nih.gov |
| Integrative analysis of multi-omic signatures and cellular function in human pancreas across developmental timeline at single-cell spatial resolution | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,809,484 | September 20, 2022 | June 30, 2027 | BRISSOVA, MARCELA | reporter.nih.gov |
| TOPMed Omics of Type 2 Diabetes and Quantitative Traits | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,776,534 | April 1, 2008 | December 31, 2025 | MANNING, ALISA KNODLE | reporter.nih.gov |
| Training Grant in Diabetes and Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,771,631 | July 1, 1977 | June 30, 2027 | GOODYEAR, LAURIE J | reporter.nih.gov |
| Effect of diabetes and AD pathology on brain imaging and cognition in Latino adults | NIH | National Institute on Aging | 2022 | $3,755,733 | September 30, 2022 | August 31, 2025 | YASSINE, HUSSEIN N | reporter.nih.gov |
| Preventing Diabetes in Latino Families | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,739,489 | December 23, 2015 | July 31, 2027 | SHAIBI, GABRIEL QUANTUM | reporter.nih.gov |
| Pathogenesis of youth onset pre-diabetes and Type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,716,431 | September 22, 2016 | July 31, 2026 | CAPRIO, SONIA | reporter.nih.gov |
| An interactive resource to generate and provide integrated knowledge of the human pancreas | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,713,324 | February 1, 2024 | November 30, 2028 | GAULTON, KYLE JEFFRIE | reporter.nih.gov |
| Blood Pressure, Obesity, and Diabetes in Relation to Perinatal and Postpartum Complications | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,700,262 | April 1, 2021 | March 31, 2027 | ZHU, YEYI | reporter.nih.gov |
| Restoring Central Regulation of Glucose Production in Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,695,446 | June 15, 2006 | April 30, 2027 | HAWKINS, MEREDITH A | reporter.nih.gov |
| Immunometabolic impact of stress hyperglycemia on tuberculosis treatment outcomes and risk of diabetes mellitus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,694,016 | March 4, 2021 | February 28, 2027 | MAGEE, MATTHEW JAMES | reporter.nih.gov |
| Targeting galectin-3 to overcome insulin resistance in type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $3,674,654 | May 22, 2020 | August 31, 2025 | AHMED, HAFIZ | reporter.nih.gov |
| Clock modulation in circadian desynchrony induced diabetes and atherovascular disease - mechanisms and interventions | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,665,703 | July 20, 2021 | April 30, 2027 | YECHOOR, VIJAY K | reporter.nih.gov |
| Using ex vivo, in vivo models and patient mutations to interrogate pancreatic exocrine-endocrine cross talk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,664,508 | September 20, 2022 | June 30, 2027 | KULKARNI, ROHIT N. | reporter.nih.gov |
| Optimizing a scalable intervention to maximize guideline-recommended diabetes testing after GDM | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,616,179 | September 12, 2021 | July 31, 2027 | BROWN, SUSAN DENISE | reporter.nih.gov |
| Human Pancreas Analysis Program-T2D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $3,605,999 | September 22, 2019 | December 31, 2025 | POWERS, ALVIN C | reporter.nih.gov |
| ENICTO Consortium Coordinating Center | NIH | National Cancer Institute | 2022 to 2025 | $3,605,131 | August 8, 2022 | June 30, 2027 | EVANS, SCOTT | reporter.nih.gov |
| Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,569,593 | April 1, 2019 | April 30, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| Diabetes, Endocrinology & Metabolism Training Grant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,532,948 | July 1, 1981 | June 30, 2027 | HSIAO, EDWARD C | reporter.nih.gov |
| Research Coordination for Outreach, Recruitment, and Retention of Adolescents At-Risk for Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,484,259 | April 1, 2022 | March 31, 2027 | SHOMAKER, LAUREN BERGER | reporter.nih.gov |
| Exploring the consequences of food insecurity and harnessing the power of peer navigation and mHealth to reduce food insecurity and cardiometabolic comorbidities among persons with HIV | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,478,756 | August 4, 2021 | June 30, 2027 | RHODES, SCOTT D | reporter.nih.gov |
| Disparities in cardiovascular health in young adults with type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,472,802 | September 1, 2024 | May 31, 2028 | DABELEA, DANA | reporter.nih.gov |
| Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with Prediabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,461,897 | July 9, 2021 | April 30, 2027 | GUTIERREZ, ABSALON DENNIS | reporter.nih.gov |
| Personalized Dietary Management in Type 2 Diabetes | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,459,318 | January 15, 2021 | November 30, 2026 | POPP, COLLIN JEFFREY | reporter.nih.gov |
| Reducing Clinical Inertia in Obesity Management of Diabetes in Primary Care: Cluster-Randomized Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,445,701 | May 1, 2021 | April 30, 2027 | O'CONNOR, PATRICK J | reporter.nih.gov |
| Exercise Regulation of Glucose Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,417,714 | September 16, 2013 | January 31, 2028 | GOODYEAR, LAURIE J | reporter.nih.gov |
| Mitochondrial ADP privation: A unifying model for glucose-induced insulin secretion. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,413,027 | April 1, 2021 | March 31, 2027 | KIBBEY, RICHARD G | reporter.nih.gov |
| Ensuring the cultural relevance of Dietary Guidelines diet patterns among African Americans: Increasing dietary quality and reducing type 2 diabetes risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,398,571 | April 1, 2021 | March 31, 2027 | TURNER-MCGRIEVY, GABRIELLE MICHELLE | reporter.nih.gov |
| Cholesterol reduction and cardiovascular risk in Type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,394,086 | August 5, 2022 | July 31, 2027 | GOLDBERG, IRA J | reporter.nih.gov |
| Targeting ADAM17 activity for correction of vascular insulin resistance in type 2 diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,391,982 | March 1, 2021 | February 28, 2027 | MARTINEZ-LEMUS, LUIS A | reporter.nih.gov |
| Microphysiological systems for modeling autoimmunity in type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,372,768 | August 2, 2019 | July 31, 2025 | STANGER, BEN Z | reporter.nih.gov |
| Comparing Two Dietary Approaches for Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,368,318 | July 1, 2021 | April 30, 2027 | SASLOW, LAURA | reporter.nih.gov |
| EXpanding Technology-Enabled, Nurse-Delivered Chronic Disease Care (EXTEND) | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,368,082 | March 15, 2021 | December 31, 2026 | SHAW, RYAN JEFFREY | reporter.nih.gov |
| Impact of Disparities in Food Security on Glycemic Control and Health CareUtilization Among Youth and Young Adults with Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,349,600 | April 1, 2018 | March 31, 2028 | LIESE, ANGELA D | reporter.nih.gov |
| Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,348,311 | December 1, 2021 | November 30, 2026 | HE, JOHN CIJIANG | reporter.nih.gov |
| The ADELANTE Trial: Testing a multi-level approach for improving household food insecurity and glycemic control among Latinos with diabetes | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,338,309 | August 4, 2021 | April 30, 2027 | ROSAS, LISA GOLDMAN | reporter.nih.gov |
| The function and regulation of the novel pregnancy-specific hexokinase HKDC1 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,336,579 | September 21, 2015 | July 31, 2025 | LAYDEN, BRIAN THOMAS | reporter.nih.gov |
| Randomized comparison of the clinical Outcome of single versus Multiple Arterial grafts: Quality of Life (ROMA:QOL) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,332,837 | April 21, 2020 | March 31, 2026 | GAUDINO, MARIO FL | reporter.nih.gov |
| Hydrogels for human beta cell survival, function and evasion of immune rejection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,331,035 | September 15, 2022 | May 31, 2027 | GARCIA, ANDRES J | reporter.nih.gov |
| Engineering synthetic immune cells with modular sentinel and therapeutic functions for T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,328,254 | April 1, 2022 | September 30, 2026 | LIM, WENDELL A | reporter.nih.gov |
| Developmental genes, miRNAs and adipose tissue | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,326,265 | December 14, 2009 | March 31, 2027 | KAHN, C RONALD | reporter.nih.gov |
| Socioecological Determinants of Immunoepigenetic Signatures of Diabetes Risk in Indigenous Communities | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,326,115 | July 28, 2021 | April 30, 2027 | MAUNAKEA, ALIKA KEOLAOKALANI | reporter.nih.gov |
| Engineering 2nd generation 5MCARs to monitor and treat Type-I Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,325,791 | April 1, 2022 | March 31, 2027 | KUHNS, MICHAEL S | reporter.nih.gov |
| Supporting, Promoting, and Launching the Expansion of Nutrition, Diabetes, and Obesity Researchers in North Carolina | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,321,489 | July 15, 2022 | May 31, 2027 | SHAIKH, SAAME R | reporter.nih.gov |
| Novel Mechanisms of Exercise Training Effects on Glucose Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,320,917 | April 10, 2014 | December 31, 2028 | GOODYEAR, LAURIE J | reporter.nih.gov |
| Apolipoprotein C3-loading of apolipoprotein B100 lipoproteins and cardiovascular disease in patients with type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,318,186 | January 5, 2022 | December 31, 2026 | HEINECKE, JAY W | reporter.nih.gov |
| Mechanisms of Tubular Atrophy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,315,146 | August 1, 2005 | June 30, 2027 | SCHELLING, JEFFREY R | reporter.nih.gov |
| Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital: Cloud-Based Real-Time Glucose Evaluation and Management System (Cyber GEMS) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,306,458 | July 27, 2021 | May 31, 2027 | PHILIS-TSIMIKAS, ATHENA | reporter.nih.gov |
| "A microbiome-dependent bile acid metabolite improves type 2 diabetes." | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,304,418 | January 8, 2021 | December 31, 2026 | SHEU, ERIC GARLAND | reporter.nih.gov |
| Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D Risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,303,112 | September 15, 2020 | June 30, 2025 | SUH, YOUSIN | reporter.nih.gov |
| Prevention of Pediatric NAFLD in Hispanic Children | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,279,874 | April 5, 2021 | January 31, 2026 | WELSH, JEAN A. | reporter.nih.gov |
| Circadian Regulation of Metabolic Risk in Mice and Women: Role of Estrogen and Time-Restricted Feeding | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,271,743 | April 1, 2021 | January 31, 2027 | PENDERGAST, JULIE S | reporter.nih.gov |
| Mechanisms of Beta Cell Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,260,500 | July 1, 2003 | July 31, 2026 | ACCILI, DOMENICO | reporter.nih.gov |
| Vascular Dysfunction in Myocardial Ischemia and Metabolic Syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,258,608 | April 1, 2016 | June 30, 2027 | SELLKE, FRANK W | reporter.nih.gov |
| Intensive Glycemic Targets in Overweight and Obese Women with Gestational Diabetes Mellitus: A Multicenter Randomized Trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,245,849 | May 1, 2021 | April 30, 2027 | SCIFRES, CHRISTINA MARIE | reporter.nih.gov |
| Telemetric Regenerative Bandage for Accelerating Wound Healing | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,240,738 | September 24, 2021 | July 31, 2027 | AMEER, GUILLERMO ANTONIO | reporter.nih.gov |
| Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians | NIH | National Human Genome Research Institute | 2022 to 2025 | $3,238,939 | September 1, 2022 | June 30, 2027 | CHIANG, CHARLESTON | reporter.nih.gov |
| Administrative supplement to "Brain Health across the Metabolic Spectrum in Youth at risk for T2D" | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,236,265 | September 11, 2021 | June 30, 2026 | HERSHEY, TAMARA G | reporter.nih.gov |
| Improving Family Functioning in Obesity Treatment for Mexican American Women | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,234,710 | August 17, 2021 | July 31, 2026 | MARQUEZ, BECKY | reporter.nih.gov |
| Promoting Preconception Care and Diabetes Self-Management among Reproductive-Aged Women with Diabetes: The PREPARED Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,218,943 | August 6, 2021 | June 30, 2027 | BAILEY, STACY C | reporter.nih.gov |
| Molecular Mechanisms of Exercise Benefits to Insulin Resistant People | NIH | National Institute on Aging | 2021 to 2025 | $3,212,676 | September 30, 2019 | July 31, 2029 | NAIR, K SREEKUMARAN | reporter.nih.gov |
| Genetic and Functional Analysis of Rapid Renal Decline in Diabetes: A Family-based Approach to Accelerate Gene Discovery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,206,577 | May 1, 2021 | April 30, 2027 | PEZZOLESI, MARCUS GUY | reporter.nih.gov |
| Early myocardial remodeling and progressive kidney function decline in type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,199,007 | December 24, 2021 | November 30, 2026 | DORIA, ALESSANDRO | reporter.nih.gov |
| Islet Dysregulation in Infants with Congenital Hyperinsulinism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,192,917 | August 15, 1999 | June 30, 2025 | DE LEON, DIVA D. | reporter.nih.gov |
| Long-Term Islet Function and Impact after Total Pancreatectomy with Islet Autotransplant (LIFT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,185,530 | January 15, 2021 | December 31, 2026 | BELLIN, MELENA D. | reporter.nih.gov |
| The role of gut microbes and microbial derived metabolites in the development of type 2 diabetes in humans | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,184,687 | August 2, 2021 | June 30, 2027 | MAJITHIA, AMIT | reporter.nih.gov |
| Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Biostatistics Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $3,184,520 | August 15, 2012 | June 30, 2025 | BRAFFETT, BARBARA HALINA | reporter.nih.gov |
| PGC1alpha Pathway: Novel Intracellular and Extracellular Mediators | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,176,373 | February 1, 2019 | June 30, 2027 | SPIEGELMAN, BRUCE M. | reporter.nih.gov |
| Metabolomic predictors of insulin resistance and diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,171,090 | August 1, 2008 | August 31, 2026 | GERSZTEN, ROBERT E | reporter.nih.gov |
| Autologous BM-MSCs and Islet Co-transplantation to Enhance Islet Survival and Function in TP-IAT Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,169,762 | August 24, 2021 | May 31, 2027 | WANG, HONGJUN | reporter.nih.gov |
| NAD+ precursor supplementation with exercise training to improve aerobic capacity in Friedreich's Ataxia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,169,156 | January 1, 2020 | December 31, 2025 | MCCORMACK, SHANA ERIN | reporter.nih.gov |
| SOLAir: Environmental Factors and Diabetes Development in Latinos | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,161,489 | September 22, 2020 | June 30, 2026 | KAUFMAN, JOEL DANIEL | reporter.nih.gov |
| Food as Medicine for HIV: A Randomized Trial of Medically Tailored Meals and Lifestyle Intervention | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,160,916 | December 1, 2020 | November 30, 2026 | BERKOWITZ, SETH A | reporter.nih.gov |
| Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,160,264 | December 24, 2021 | November 30, 2025 | KING, GEORGE L | reporter.nih.gov |
| Mechanistic and therapeutic role of the CD137-CD137L axis in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,158,683 | July 21, 2016 | June 30, 2027 | CHEN, YI-GUANG | reporter.nih.gov |
| Development and Evaluation of EHR-enabled Population Health Outreach Strategies to Improve Diabetes Screening in a Safety-net Health System: a Pragmatic Randomized Controlled Trial | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $3,149,180 | March 1, 2022 | February 28, 2027 | BOWEN, MICHAEL EDWARD | reporter.nih.gov |
| TREAT (Time Restricted EATing) to improve cardiometabolic health | NIH | National Institute on Aging | 2021 to 2024 | $3,144,883 | September 30, 2020 | June 30, 2026 | LAFERRERE, BLANDINE B | reporter.nih.gov |
| FFA Metabolism in Different Types of Human Obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,144,434 | August 1, 1988 | July 31, 2028 | JENSEN, MICHAEL D. | reporter.nih.gov |
| New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,142,274 | September 20, 2021 | June 30, 2026 | VU, SIMON | reporter.nih.gov |
| Harnessing Novel Human Endocrine Progenitor Biology for Enhanced Generation of Beta Cells from Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,140,632 | September 1, 2025 | August 31, 2029 | SNEDDON, JULIE BETH | reporter.nih.gov |
| Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,134,067 | June 1, 2019 | March 31, 2027 | WANG, HONGJUN | reporter.nih.gov |
| A Randomized Control Trial to improve metabolic outcomes in African American pregnant women | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,118,072 | August 20, 2021 | April 30, 2027 | IZCI BALSERAK, BILGAY | reporter.nih.gov |
| Microbiota-immune interactions that promote intestinal homeostasis | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,111,145 | June 15, 2021 | May 31, 2026 | ROUND, JUNE LOUISE | reporter.nih.gov |
| Role of Lipogenic Pathways in Intestinal Remodeling after Gastric Bypass Surgery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,103,125 | September 3, 2025 | September 2, 2029 | STEFATER-RICHARDS, MARGARET | reporter.nih.gov |
| Engineering T cells to Promote Islet Transplant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,102,316 | April 1, 2022 | March 31, 2027 | RILEY, JAMES L. | reporter.nih.gov |
| Regulation of Myocardial Phospholipases and Lipases in Diabetic Myocardium | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,101,106 | June 1, 2013 | January 31, 2026 | GROSS, RICHARD W | reporter.nih.gov |
| Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,099,608 | August 2, 2021 | June 30, 2027 | GRIFFIN, DONALD RICHIERI | reporter.nih.gov |
| Engineered Immune Cells for T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,097,818 | April 1, 2022 | March 31, 2026 | MEYER, EVERETT | reporter.nih.gov |
| Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,096,729 | September 12, 2022 | May 31, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| HIV, Depression, and Insulin Resistance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,096,280 | September 1, 2025 | August 31, 2029 | GUPTA, SAMIR KUMAR | reporter.nih.gov |
| Modeling diabetes using an integrated plate system | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $3,092,998 | September 20, 2018 | July 31, 2024 | WELLS, JAMES M | reporter.nih.gov |
| Determination of the mechanistic targets of metformin | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,082,292 | September 30, 2020 | June 30, 2025 | REDDY, AKHILESH BASI | reporter.nih.gov |
| Influence of Nocturnal Light Exposure on the Impairment of Glucose Tolerance Induced by Chronic Sleep Restriction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,081,704 | July 29, 2021 | April 30, 2025 | CZEISLER, CHARLES A | reporter.nih.gov |
| Administrative Supplement to Promote Diversity in Research and Development Small Businesses-SBIR (EF) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,074,836 | April 15, 2020 | March 31, 2024 | KALE, KAUSTUBH | reporter.nih.gov |
| Advanced Artificial Pancreas Systems to Enable Fully Automated Glycemic Control in Type 1 Diabetes Mellitus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,074,490 | September 12, 2021 | July 31, 2027 | BRETON, MARC D | reporter.nih.gov |
| NIDDK Diabetic Foot Consortium Clinical Research Unit | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,070,460 | September 15, 2018 | December 31, 2027 | HOLMES, CRYSTAL MURRAY | reporter.nih.gov |
| Intensive Lifestyle Intervention, Metabolomics, and Risk of Frailty Fracture in Overweight or Obese Patients with Type 2 Diabetes | NIH | National Institute on Aging | 2021 to 2025 | $3,069,231 | September 30, 2021 | May 31, 2027 | ZHAO, QI | reporter.nih.gov |
| Animal Models for Studying the Genetics of Complex Diseases | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,068,389 | September 30, 1992 | December 31, 2026 | MAEDA, NOBUYO | reporter.nih.gov |
| Immunometabolic regulations of pulmonary TB pathogenesis by adiposetissue | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,053,206 | January 10, 2020 | December 31, 2025 | NAGAJYOTHI, JYOTHI FALGUNI | reporter.nih.gov |
| PanKbase: a community hub for integrated pancreas knowledge | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,048,518 | February 1, 2024 | November 30, 2028 | PARKER, STEPHEN CJ | reporter.nih.gov |
| DREAM Complex Maintenance of Human Beta Cell Quiescence | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,048,223 | July 1, 2021 | May 31, 2026 | STEWART, ANDREW F. | reporter.nih.gov |
| Mechanisms for regulation of a novel class of anti-diabetic lipids | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,048,217 | April 20, 2016 | September 30, 2025 | KAHN, BARBARA B. | reporter.nih.gov |
| Latinos Understanding the Need for Adherence in Diabetes using Care Coordination, Integrated Medical and Behavioral Care and E-Health (LUNA-E) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,041,154 | June 8, 2021 | July 1, 2026 | TALAVERA, GREGORY A | reporter.nih.gov |
| Sex Differences in the Metabolic Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $3,040,428 | September 20, 2018 | July 31, 2023 | REUE, KAREN | reporter.nih.gov |
| Intracranial arterial compliance, cerebral blood flow, and dementia risk in older adults with type 2 diabetes | NIH | National Institute on Aging | 2021 to 2024 | $3,038,302 | May 1, 2020 | February 28, 2026 | BANGEN, KATHERINE | reporter.nih.gov |
| Unrecognized Primary Aldosteronism as a Pathogenic Mechanism for Chronic Kidney Disease in Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,037,827 | April 1, 2018 | May 31, 2029 | VAIDYA, ANAND | reporter.nih.gov |
| Metabolic Impacts of Type II Interferon Signals in Obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,025,782 | August 18, 2017 | June 30, 2027 | HARTIG, SEAN | reporter.nih.gov |
| Engineering a Human Microphysiological System for the Characterization of Islet-Immune Interactions | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,023,310 | August 1, 2019 | July 31, 2025 | STABLER, CHERIE L | reporter.nih.gov |
| Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia | NIH | National Institute on Aging | 2021 to 2024 | $3,021,014 | August 15, 2020 | April 30, 2026 | GRANT, RICHARD W | reporter.nih.gov |
| Heightened hypoxia and DNA methylation in heart defects of diabetic embryopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,020,733 | September 15, 2022 | July 31, 2027 | YANG, PEIXIN | reporter.nih.gov |
| Extracellular Vesicle-mediated islet immune cross talk in Type 1 Diabetes pathogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,020,296 | September 15, 2022 | April 30, 2027 | REIJONEN, HELENA KRISTIINA | reporter.nih.gov |
| A 3D vascularized islet biomimetic to model type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,017,660 | August 1, 2019 | January 31, 2025 | SANDER, MAIKE | reporter.nih.gov |
| Identifying cell-type specific genetic control of T1D risk variants in TEDDY | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,014,326 | February 1, 2024 | January 31, 2027 | ONENGUT, SUNA | reporter.nih.gov |
| Effects of a Novel, Scalable, and Sustainable Patient Portal Intervention on Diabetes-Related Outcomes: A Pragmatic Randomized Controlled Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,013,751 | September 20, 2021 | August 31, 2025 | MARTINEZ, WILLIAM | reporter.nih.gov |
| Admin Supplement to "Breaking up sedentary behaviors to improve glucose control in a population at risk for developing type 2 diabetes" | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,007,877 | December 15, 2020 | November 30, 2026 | BERGOUIGNAN, AUDREY | reporter.nih.gov |
| Non-Clinical Pharmacology of CX-01 | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,007,043 | June 1, 2014 | January 31, 2027 | VID, GALINA | reporter.nih.gov |
| Improving Glycemia & Reducing Diabetes Distress in Adolescents & Young Adults with T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,003,444 | August 25, 2021 | July 31, 2025 | LAFFEL, LORI M | reporter.nih.gov |
| Characterization of beta-cell-specific extracellular vesicle cargo as functional biomarkers for type I DM disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,000,544 | September 19, 2022 | July 31, 2027 | DAS, SAUMYA | reporter.nih.gov |
| Development of a Novel Chemokine Receptor Antagonist Peptide as a Non-Opioid Treatment for Relief of Chronic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,999,505 | September 15, 2021 | August 31, 2023 | RUFF, MICHAEL R | reporter.nih.gov |
| A Shared Decision Making Intervention for Diabetes Prevention in Women with a History of Gestational Diabetes Mellitus. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,998,294 | February 15, 2021 | November 30, 2026 | DURU, OBIDIUGWU KENRIK | reporter.nih.gov |
| Role of 12-lipoxygenase and 12-HETE signaling in beta-cell dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,984,916 | April 1, 2015 | March 31, 2026 | MIRMIRA, RAGHAVENDRA G | reporter.nih.gov |
| Proteomic analysis of hydroxychloroquine prevention trials in T1D, RA and SLE | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $2,978,715 | August 18, 2023 | July 31, 2028 | BUCKNER, JANE HOYT | reporter.nih.gov |
| Translational control underlies nutrition and metabolism in health and disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,971,227 | September 4, 2025 | August 31, 2029 | RUGGERO, DAVIDE | reporter.nih.gov |
| Early detection of type 1 diabetes via Exosome Technology with Optoelectronics Lab-on-chip: EXTOL | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,971,174 | September 15, 2022 | April 30, 2026 | LEE, LUKE P. | reporter.nih.gov |
| Discordant transcriptional regulation of gluconeogenic and lipogenic gene expression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,971,019 | June 15, 2016 | June 30, 2026 | PESSIN, JEFFREY E. | reporter.nih.gov |
| Paternal Contributions to Metabolic Disease in Offspring: Environment, Epigenetics, and Sperm | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,970,989 | September 1, 2021 | May 31, 2026 | PATTI, MARY E | reporter.nih.gov |
| Human on a chip systems to investigate disease comorbidities common in the aged population | NIH | National Institute on Aging | 2021 to 2022 | $2,967,932 | April 1, 2018 | April 30, 2025 | SHULER, MICHAEL L | reporter.nih.gov |
| SOCRATES: SOCial Risk and diAbetes ouTcomEs Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,966,988 | September 1, 2021 | July 31, 2027 | BERKOWITZ, SETH A | reporter.nih.gov |
| Effects of Glycation and Carbonylation on MHC II-restricted immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,960,100 | February 18, 2020 | January 31, 2026 | SANTAMBROGIO, LAURA | reporter.nih.gov |
| Diabetes, Endocrine, and Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,956,846 | September 15, 1978 | June 30, 2026 | STOFFERS, DORIS A | reporter.nih.gov |
| Improving Diabetic Patients’ Adherence to Treatment and Prevention of Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,952,168 | July 15, 2020 | April 30, 2026 | OLOMU, ADESUWA B | reporter.nih.gov |
| Identifying and preventing antigen specific T cells in diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,951,339 | June 22, 2021 | May 31, 2027 | FIFE, BRIAN T | reporter.nih.gov |
| Extremely high-throughput mapping of protein, RNA, and chromatin interactions in health and disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,945,203 | July 30, 2020 | June 30, 2025 | ZHONG, SHENG | reporter.nih.gov |
| Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,942,639 | July 1, 2023 | June 30, 2027 | KIEVIT, PAUL | reporter.nih.gov |
| BRinging the Diabetes Prevention Program to GEriatric Populations (BRIDGE) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,941,252 | December 1, 2021 | November 30, 2026 | BEASLEY, JEANNETTE MICHELE | reporter.nih.gov |
| Resistance Training Modulation of Fat Metabolism in Obese Postmenopausal Women | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,940,089 | May 1, 2021 | April 30, 2027 | HICKNER, ROBERT C | reporter.nih.gov |
| Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,937,157 | May 15, 2022 | April 30, 2027 | WONG, WILSON | reporter.nih.gov |
| UCSF Diabetic Foot Clinical Research Unit | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,932,202 | September 15, 2018 | December 31, 2027 | CONTE, MICHAEL S | reporter.nih.gov |
| Moderately CHO-restricted diet as treatment targeting improvement in hepatic lipid and insulin sensitivity in adolescents with NAFLD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,928,802 | May 5, 2021 | July 31, 2026 | GOSS, AMY MISKIMON | reporter.nih.gov |
| Role of Adiposomes in Diabetes-Associated Endothelial Dysfunction and Restorative Effects of Exercise and Metabolic Surgery | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,928,645 | January 1, 2022 | December 31, 2026 | MOHAMED, ABEER M | reporter.nih.gov |
| The Effects of Neprilysin Inhibition on Cardiometabolic Health in Black Individuals | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,925,074 | June 1, 2022 | May 31, 2027 | ARORA, PANKAJ | reporter.nih.gov |
| Advancing an accessible, high-throughput and multiplex islet autoantibody test with self-collected capillary dried blood spots for regulatory clearance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,919,236 | August 1, 2016 | May 31, 2026 | SEFTEL, DAVID | reporter.nih.gov |
| Metformin in Pregnancy: Fetal Consequences & Long-term offspring Outcomes in a NHP model | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,914,182 | April 19, 2024 | July 31, 2027 | KIEVIT, PAUL | reporter.nih.gov |
| iSTAR Tregs | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,906,574 | July 1, 2023 | June 30, 2027 | TANG, QIZHI | reporter.nih.gov |
| Improving Self-Regulation and Social Support for Type 1 Diabetes During Emerging Adulthood | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,899,970 | May 1, 2022 | April 30, 2027 | BERG, CYNTHIA A | reporter.nih.gov |
| Alterations in Post-Receptor Insulin Signaling in Diabetes and Insulin Resistance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,895,718 | September 17, 2021 | June 30, 2027 | KAHN, C RONALD | reporter.nih.gov |
| Enhancement of autoimmunity in type 1 diabetes by gluten | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,890,025 | September 17, 2021 | August 31, 2027 | CHERVONSKY, ALEXANDER V | reporter.nih.gov |
| Mechanisms for activation of beige adipose tissue in humans | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,884,600 | December 1, 2020 | November 30, 2026 | KERN, PHILIP A | reporter.nih.gov |
| UPMC Clinical Center for the Study of Chronic Pancreatitis and Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,876,366 | September 28, 2015 | June 30, 2030 | YADAV, DHIRAJ | reporter.nih.gov |
| Sedentary behavior, physical activity, sleep, and cardiovascular risk in pregnancy: the Pregnancy 24/7 cohort study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,868,051 | September 15, 2020 | August 31, 2025 | WHITAKER, KARA MARIE | reporter.nih.gov |
| Nitro-Fatty Acids and Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,867,343 | August 1, 2022 | June 30, 2027 | CHEN, YUQING EUGENE | reporter.nih.gov |
| Translation of the UVA Advanced Automated Insulin Delivery Systems to Clinical Care in Young Children: Glycemic Control, Regulatory Acceptance and Optimization of Day to Day Use | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,865,164 | September 17, 2020 | June 30, 2024 | BRETON, MARC D | reporter.nih.gov |
| Characterize the Landscape and Origin of Hybrid Peptides in Beta Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,864,714 | September 25, 2018 | June 30, 2027 | DELONG, THOMAS | reporter.nih.gov |
| Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,862,122 | July 21, 2023 | June 30, 2027 | QIAN, WEI-JUN | reporter.nih.gov |
| DYRK Inhibitors for Human Beta Cell Expansion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,843,760 | March 1, 2016 | May 31, 2025 | STEWART, ANDREW F. | reporter.nih.gov |
| The role of senescent beta cells in T1D and T2D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,840,914 | September 19, 2022 | June 30, 2027 | KAESTNER, KLAUS H | reporter.nih.gov |
| Development of platforms for beta cell-specific delivery and ligand discovery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,837,648 | July 1, 2023 | June 30, 2027 | CHOUDHARY, AMIT | reporter.nih.gov |
| HIV, gestational diabetes and TB in pregnancy | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,837,523 | July 15, 2022 | June 30, 2027 | MATHAD, JYOTI S | reporter.nih.gov |
| Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial | NIH | National Institute on Aging | 2021 to 2024 | $2,834,493 | February 15, 2020 | January 31, 2025 | ROVNER, BARRY W. | reporter.nih.gov |
| Glucose patterns and cardiac arrhythmias in older adults with diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,826,986 | April 1, 2022 | March 31, 2027 | SELVIN, ELIZABETH | reporter.nih.gov |
| A novel psychological-behavioral intervention to promote physical activity in type 2 diabetes. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,826,305 | July 1, 2022 | May 31, 2027 | HUFFMAN, JEFF C | reporter.nih.gov |
| Polyamines and Hypusine in Type 1 Diabetes Pathogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,825,507 | May 7, 2020 | July 31, 2030 | MIRMIRA, RAGHAVENDRA G | reporter.nih.gov |
| Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,817,305 | July 1, 2022 | April 30, 2027 | TANG, QIZHI | reporter.nih.gov |
| Multimarker surface signatures of human islet derived extracellular vesicles | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,815,725 | September 22, 2022 | May 31, 2027 | ROUTENBERG, DAVID AARON | reporter.nih.gov |
| Treating early type 2 diabetes by reducing postprandial glucose excursions: A paradigm shift in lifestyle modification | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,811,988 | July 1, 2022 | May 31, 2027 | FABRIS, CHIARA | reporter.nih.gov |
| Supplement to Center for Excellence in Diabetes and Obesity Research: Implementing Biomechanics Instrumentation in the Diabetes and Obesity Center | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $2,809,998 | July 1, 2018 | June 30, 2024 | JONES, STEVEN P | reporter.nih.gov |
| Role of Microvascular insulin resistance and cardiorespiratory fitness in diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,802,422 | April 1, 2021 | March 31, 2027 | REUSCH, JANE E | reporter.nih.gov |
| Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,801,471 | January 1, 2011 | April 30, 2026 | NATARAJAN, RAMA | reporter.nih.gov |
| Healthy for 2/Healthy for U: A Pragmatic Randomized Clinical Trial to Limit Gestational Weight Gain and Prevent Obesity in the Prenatal Care Setting | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,797,717 | March 10, 2020 | February 28, 2026 | BENNETT, WENDY LYNET | reporter.nih.gov |
| Discovery of diabetes-relevant ò cell enhancers through 4D enhancer mapping, integrative analysis, and large-scale CRISPRi perturbation screens | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,792,424 | September 15, 2020 | June 30, 2025 | HUANGFU, DANWEI | reporter.nih.gov |
| Estrogen Regulation of Fetal Microvessel Development During Primate Pregnancy: Impact on Insulin Sensitivity in Offspring | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,790,596 | April 22, 2020 | January 31, 2026 | ALBRECHT, EUGENE D. | reporter.nih.gov |
| Whole Protein Arrays to Detect Antimicrobial Antibodies Associated with Triggering and Progression of Islet Autoimmunity in TEDDY | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,788,474 | September 5, 2024 | August 31, 2027 | LABAER, JOSHUA | reporter.nih.gov |
| Elastic, Degradable Vascular Grafts with Helical Microfibers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,787,042 | August 15, 2021 | July 31, 2025 | WANG, YADONG | reporter.nih.gov |
| Molecular mechanism of metabolic stress in the pancreatic beta cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,782,476 | September 1, 2025 | August 31, 2029 | WANG, YUE | reporter.nih.gov |
| Survival and potential of insulin-deficient beta cells in type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,780,326 | September 20, 2022 | June 30, 2027 | SCHATZ, DESMOND ARTHUR | reporter.nih.gov |
| Metabolic Markers and Predictors of Childhood Obesity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,780,011 | June 1, 1991 | February 28, 2026 | CAPRIO, SONIA | reporter.nih.gov |
| The Louisiana Center for Advancing Uplifting Scientists Careers in Health, Nutrition, Obesity, and Diabetes Research (LAUNCHED) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,779,948 | July 15, 2022 | May 31, 2027 | NEWTON, ROBERT LEE | reporter.nih.gov |
| Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,778,087 | July 1, 2022 | April 30, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| The regulation of fasting glucose metabolism in people with and without prediabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,776,545 | August 1, 2007 | May 31, 2029 | VELLA, ADRIAN | reporter.nih.gov |
| Building Equity Improvement into Quality Improvement in the use of New Glucose-lowering Drugs (GLDs) through Individualized Drug Value Assessment in People with Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,776,501 | July 20, 2022 | June 30, 2026 | GUO, JINGCHUAN | reporter.nih.gov |
| Biobehavioral Human-Machine Co-adaptation of the Artificial Pancreas | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,773,326 | September 28, 2009 | March 31, 2026 | KOVATCHEV, BORIS P | reporter.nih.gov |
| Beta cell Notch activity in Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,773,102 | April 1, 2022 | March 31, 2027 | PAJVANI, UTPAL | reporter.nih.gov |
| Inflammatory mediators of cardiometabolic risk in Latinos | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,772,602 | January 1, 2020 | December 31, 2025 | AVERY, CHRISTY LEIGH | reporter.nih.gov |
| Defining the role of MafA in islet beta cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,772,028 | July 29, 2011 | May 31, 2027 | STEIN, ROLAND W | reporter.nih.gov |
| Metabolic Health during Puberty: the Healthy Start Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,770,519 | July 1, 2022 | June 30, 2027 | DABELEA, DANA | reporter.nih.gov |
| The Impact of the Food Environment and Other Environmental Exposures on the Risk of Diabetes in Rural Settings | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,769,055 | July 1, 2020 | March 31, 2026 | LEE, DAVID C | reporter.nih.gov |
| Targeting GLP-1 receptor as a new chronotherapy against nondipping blood pressure in diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,767,043 | June 15, 2022 | May 31, 2027 | GONG, MING C | reporter.nih.gov |
| The effect of endogenous GLP-1 secretion on islet function in vivo | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,764,176 | July 1, 2020 | June 30, 2030 | VELLA, ADRIAN | reporter.nih.gov |
| Glycemic Observation Using A1C for Gestational Diabetes Diagnosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,763,366 | June 15, 2022 | May 31, 2027 | POWE, CAMILLE ELISE | reporter.nih.gov |
| Fetal and Early Postnatal Influences on Child Metabolic Health After Gestational Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,761,182 | May 6, 2020 | April 30, 2025 | GUNDERSON, ERICA PAULINE | reporter.nih.gov |
| Divergent Mechanisms Underlying Anorexic and Antidiabetic Actions of FGF1 in the Brain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,758,791 | September 1, 1994 | June 30, 2026 | SCHWARTZ, MICHAEL W | reporter.nih.gov |
| Micro-nanotechnologies for the analysis of islet-derived extracellular vesicles implicated in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,758,753 | September 19, 2022 | June 30, 2027 | NG, ALPHONSUS | reporter.nih.gov |
| New Risk Models for Diabetes Complications Using Electronic Health Records | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,749,048 | April 1, 2022 | March 31, 2027 | NAU, CLAUDIA LEONIE | reporter.nih.gov |
| Long-Acting RNAi Therapy for Atherosclerosis and Insulin Resistance | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,745,822 | July 1, 2021 | June 30, 2026 | SHI, JINJUN | reporter.nih.gov |
| Gluconeogenesis and Glycogenolysis - Role and Regulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,745,503 | June 1, 1978 | July 31, 2029 | EDGERTON, DALE S | reporter.nih.gov |
| Blood Sugar Sensing on Maintenance Dialysis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,740,674 | August 21, 2020 | May 31, 2030 | DE BOER, IAN H | reporter.nih.gov |
| Wearable Metabolic Sensor for Monitoring of Lactate and Glucose for People with Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,738,039 | September 1, 2021 | May 31, 2028 | TANGNEY, JARED RYLAN | reporter.nih.gov |
| Novel Targets for Reducing Atherosclerosis in Type 1 Diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,734,575 | December 1, 2021 | November 30, 2026 | BIDDINGER, SUDHA B | reporter.nih.gov |
| Clinical relevance of glucose patterns in older adults | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,730,589 | March 1, 2021 | February 28, 2026 | SELVIN, ELIZABETH | reporter.nih.gov |
| Measuring Early Pregnancy Glycemia and Its Impact on Adverse Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $2,729,506 | September 20, 2019 | July 31, 2025 | POWE, CAMILLE ELISE | reporter.nih.gov |
| Pathogenesis of Dyslipidemia and Atherosclerosis in the Diabetic State | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,729,452 | September 1, 2011 | June 30, 2025 | BIDDINGER, SUDHA B | reporter.nih.gov |
| Nlrp3 inflammasome activation in early diabetic retinopathy | NIH | National Eye Institute | 2021 to 2024 | $2,726,569 | September 1, 2020 | May 31, 2025 | AMBATI, JAYAKRISHNA | reporter.nih.gov |
| Implications of Changes in Islet Exosomal Cargo in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,718,093 | September 19, 2022 | July 31, 2027 | SIMS, EMILY K | reporter.nih.gov |
| Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,716,368 | January 1, 2021 | December 31, 2025 | CURRAN, JOANNE E. | reporter.nih.gov |
| The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,716,071 | September 28, 2015 | June 30, 2030 | VEGE, SANTHI SWAROOP | reporter.nih.gov |
| Causal connections between axon guidance proteins and early progressive kidney function decline in diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,713,884 | April 1, 2022 | January 31, 2027 | KROLEWSKI, ANDRZEJ S | reporter.nih.gov |
| University of Minnesota Clinical Center for the Study of Pancreatic Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,713,570 | September 3, 2020 | June 30, 2030 | BELLIN, MELENA D. | reporter.nih.gov |
| Development of Prognostic Algorithms to Identify Subjects at High Risk of ESKD in Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,712,858 | September 20, 2021 | July 31, 2025 | KROLEWSKI, ANDRZEJ S | reporter.nih.gov |
| Adaptive epigenetic mechanisms of beta and immune cells in autoimmune diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,708,550 | July 15, 2021 | June 30, 2025 | HEROLD, KEVAN C | reporter.nih.gov |
| ADAPTIVE MOTIF-BASED CONTROL (AMBC): A FUNDAMENTALLY NEW APPROACH TO AUTOMATED TREATMENT OPTIMIZATION FOR TYPE 1 DIABETES | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,707,952 | August 17, 2022 | May 31, 2027 | KOVATCHEV, BORIS P | reporter.nih.gov |
| Towards optimizing diabetes management and diagnosis by personalizing HbA1c targets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,706,819 | July 1, 2020 | March 31, 2026 | COHEN, ROBERT MAYNARD | reporter.nih.gov |
| Diabetes Research Training Program | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,704,717 | July 1, 2017 | June 30, 2027 | NORRIS, ANDREW W | reporter.nih.gov |
| COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City. | NIH | National Institute on Aging | 2022 to 2025 | $2,701,968 | September 30, 2022 | June 30, 2027 | DODSON, JOHN A | reporter.nih.gov |
| LRRC8 anion channels, superoxide and RhoA in diabetic erectile dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,699,596 | May 1, 2022 | April 30, 2027 | WEBB, R CLINTON | reporter.nih.gov |
| Role of neuraminidase activity on endothelial dysfunction in type 2 diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,698,865 | June 10, 2021 | May 31, 2026 | MARTINEZ-LEMUS, LUIS A | reporter.nih.gov |
| Long-acting Stable Glucagons for Treatment of Hyperinsulinism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $2,693,389 | September 18, 2017 | July 31, 2025 | FLUDZINSKI, PAWEL | reporter.nih.gov |
| B-lymphocyte Targeting Therapies for Autoimmune Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,678,494 | April 1, 2013 | March 31, 2026 | SERREZE, DAVID V | reporter.nih.gov |
| Mechanisms of mucociliary dysfunction in cystic fibrosis related diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,678,041 | April 1, 2021 | March 31, 2026 | SALATHE, MATTHIAS A | reporter.nih.gov |
| Evaluation of the entero-insular (incretin) axis in cystic fibrosis-competitive renewal. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,675,883 | September 17, 2012 | June 30, 2026 | KELLY, ANDREA BRIDGET | reporter.nih.gov |
| Time-restricted feeding to mitigate metabolic impairments during circadian misalignment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,673,850 | August 12, 2020 | June 30, 2026 | BROUSSARD, JOSIANE | reporter.nih.gov |
| Insulin Receptor Structure and Turnover | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,668,398 | April 15, 1982 | February 28, 2026 | KAHN, C RONALD | reporter.nih.gov |
| The Origin, Dynamics, and Function of Postnatal Beige Adipocytes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,663,539 | April 1, 2019 | May 31, 2029 | COHEN, PAUL | reporter.nih.gov |
| Multi-isotope Hybrid PET/CT Imaging of Peripheral Artery Disease in Diabetes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,663,222 | December 19, 2022 | November 30, 2025 | SINUSAS, ALBERT J | reporter.nih.gov |
| SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,658,806 | June 1, 1998 | June 30, 2027 | DEFRONZO, RALPH A | reporter.nih.gov |
| Autoimmune Stem-like CD8 T cells in Type 1 Diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,657,421 | June 8, 2023 | May 31, 2028 | SCHIETINGER, ANDREA | reporter.nih.gov |
| Antimicrobial dermal matrices to promote infection free wound closure in DTU-DFUs. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $2,649,424 | September 1, 2023 | August 31, 2025 | MEHTA, MANAV | reporter.nih.gov |
| Modulating intrinsic beta cell stress to block diabetes pathogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,648,788 | August 15, 2021 | June 30, 2025 | PAPA, FEROZ R | reporter.nih.gov |
| Linking education, produce provision, and community referrals to improve diabetes care (LINK) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,646,436 | April 1, 2022 | March 31, 2027 | JOSEPH, JOSHUA J | reporter.nih.gov |
| Type 1 diabetes genetic risk scores for the diagnosis of diabetes type in children of diverse racial and ethnic background | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,640,074 | February 15, 2021 | January 31, 2026 | REDONDO, MARIA JOSE | reporter.nih.gov |
| Health Impacts of City-Wide Zero-Fare Bus Transit: A Natural Experiment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,639,411 | April 15, 2022 | January 31, 2027 | BERKLEY-PATTON, JANNETTE YVONNE | reporter.nih.gov |
| Ketones, Muscle Metabolism, and SGLT2 Inhibitors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,636,697 | July 15, 2016 | March 31, 2027 | DEFRONZO, RALPH A | reporter.nih.gov |
| Natural History of Pre-Diabetic Autoimmunity (DAISY) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,635,445 | November 1, 1994 | April 30, 2026 | REWERS, MARIAN J | reporter.nih.gov |
| Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,634,144 | August 12, 2022 | July 31, 2026 | ANDERSON, MARK S | reporter.nih.gov |
| Modulating pathogenic T cells in Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,630,520 | April 1, 2000 | May 31, 2029 | HEROLD, KEVAN C | reporter.nih.gov |
| Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,630,464 | April 1, 2021 | March 31, 2026 | FLOREZ, JOSE CARLOS | reporter.nih.gov |
| Effects of Exercise and GLP-1R Agonism on Muscle Microvascular Perfusion and Insulin Action | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,627,320 | July 1, 2020 | April 30, 2027 | LIU, ZHENQI | reporter.nih.gov |
| NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial | NIH | National Institute on Aging | 2022 to 2024 | $2,625,739 | August 1, 2022 | July 31, 2025 | BHASIN, SHALENDER | reporter.nih.gov |
| Circulating hydrogen sulfide, diabetes and diabetes-related cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,624,897 | September 15, 2022 | August 31, 2027 | TOTAH, RHEEM ANGELA | reporter.nih.gov |
| Perfluoroalkyl substances and incident type 2 diabetes in a US population: A metabolome-genome investigation | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $2,621,521 | September 2, 2022 | June 30, 2027 | VALVI, DAMASKINI | reporter.nih.gov |
| Triglycerides as a Predictor of Newborn Subcutaneous and Liver Fat: Contributors to Fetal Fat Accretion in Obese Pregnancies | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,620,225 | May 7, 2021 | March 31, 2027 | BARBOUR, LINDA ANNE | reporter.nih.gov |
| ACT1VATE: Addressing Emotional Distress to Improve Outcomes among Diverse Adults with Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,615,237 | September 15, 2020 | August 31, 2027 | FORTMANN, ADELAIDE L | reporter.nih.gov |
| The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,613,461 | March 11, 2021 | January 31, 2027 | MOTTL, AMY | reporter.nih.gov |
| Physician Networks for Diabetic Lower Extremity Wounds | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,605,664 | September 28, 2022 | November 30, 2027 | DAMBERG, CHERYL | reporter.nih.gov |
| Testing the efficacy of multi-day interruptions in sedentary behaviors on metabolic, cognitive, and affective outcomes in youth at risk for Type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,602,669 | August 1, 2020 | July 31, 2027 | BELCHER, BRITNI RYAN | reporter.nih.gov |
| Cardiometabolic Risk Development and Management in Changing Neighborhoods: the Jackson Heart Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,601,089 | August 4, 2020 | June 30, 2026 | BARBER, SHARRELLE M | reporter.nih.gov |
| Glucagon secretion and action in humans | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,599,787 | September 25, 2017 | July 31, 2027 | VELLA, ADRIAN | reporter.nih.gov |
| Advancing the Lives & HeaLth of Youth and Young Adults with Down Syndrome (ALLY-DS) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $2,598,199 | September 17, 2024 | May 31, 2029 | KELLY, ANDREA BRIDGET | reporter.nih.gov |
| Insulin Signaling Activates Urothelial Defenses to Reduce Urinary Tract Infection Susceptibility | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,594,836 | September 24, 2021 | July 31, 2027 | SPENCER, JOHN DAVID | reporter.nih.gov |
| Pharmacogenetics of the Response to a GLP1R Agonist | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,594,030 | December 1, 2021 | November 30, 2026 | BEITELSHEES, AMBER L | reporter.nih.gov |
| miR-92a as a biomarker of diabetic retinopathy | NIH | National Eye Institute | 2021 to 2025 | $2,587,856 | September 30, 2021 | July 31, 2027 | BHATWADEKAR, ASHAY D | reporter.nih.gov |
| Activity Levels, Myosteatosis and Insulin Resistance/Diabetes Mellitus | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,587,803 | September 8, 2021 | June 30, 2025 | ALLISON, MATTHEW A | reporter.nih.gov |
| A Dietary Intervention to Improve Glucose Tolerance in Adults with Cystic Fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,582,505 | September 15, 2022 | May 31, 2027 | ALVAREZ, JESSICA ALEJANDRA | reporter.nih.gov |
| Effects of the DASH diet on glucose patterns in adults with type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,582,175 | April 1, 2021 | March 31, 2027 | SELVIN, ELIZABETH | reporter.nih.gov |
| Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,578,394 | February 7, 2020 | January 31, 2026 | MAAHS, DAVID MATTHEW | reporter.nih.gov |
| Microtubule Regulation of Pancreatic Beta Cell Function and Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,576,923 | March 1, 2016 | March 31, 2026 | KAVERINA, IRINA | reporter.nih.gov |
| Structural mechanism of diabetic amyloid formation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,575,386 | September 15, 2008 | May 31, 2029 | ZANNI, MARTIN T | reporter.nih.gov |
| COATs: Collagen-mimetic peptide and therapeutic gene-modified collagens for cell-mediated healing of diabetic foot ulcers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,574,620 | July 30, 2021 | May 31, 2027 | SULLIVAN, MILLICENT O | reporter.nih.gov |
| A functional genomics pipeline for genetic discovery in diabetic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,573,670 | August 1, 2022 | May 31, 2027 | HIRSCHHORN, JOEL N | reporter.nih.gov |
| Multi-omic genetic regulatory signatures underlying tissue complexity of diabetes in the pancreas at single-cell spatial resolution | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,572,878 | August 17, 2022 | June 30, 2027 | PARKER, STEPHEN CJ | reporter.nih.gov |
| Genetic and physiologic regulation of pig islet development and function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,572,015 | June 1, 2021 | May 31, 2025 | KIM, SEUNG K | reporter.nih.gov |
| Personal and social-built environmental factors of glucose variability among multi ethnic groups of adults with type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,570,523 | July 1, 2022 | August 31, 2026 | NAM, SOOHYUN | reporter.nih.gov |
| CRISPR-enhanced adipocyte browning to improve glucose tolerance in obesity and diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,560,135 | September 17, 2021 | June 30, 2025 | CZECH, MICHAEL P | reporter.nih.gov |
| A Multi-Level Evaluation of California's New Medicaid Coverage for the Diabetes Prevention Program | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,558,462 | July 27, 2020 | June 30, 2026 | DURU, OBIDIUGWU KENRIK | reporter.nih.gov |
| Neuropathology and inflammation in a nonhuman primate model of insulin resistance/metabolic syndrome | NIH | National Institute on Aging | 2024 to 2025 | $2,556,565 | February 15, 2024 | November 30, 2028 | HAVEL, PETER J | reporter.nih.gov |
| Effects of DDE exposure on adipose tissue function, weight loss and metabolic improvement after bariatric surgery: A new paradigm for study of lipophilic chemicals | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,550,733 | February 1, 2020 | November 30, 2025 | CHATZI, VAIA LIDA | reporter.nih.gov |
| Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,550,184 | September 15, 2022 | June 30, 2027 | ROHATGI, ANAND KUMAR | reporter.nih.gov |
| A first in human clinical study of TT101, a synthetic immunomodulatory material to build new functional tissue over exposed bone as a one time treatment for diabetic limb preservation patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,549,496 | September 15, 2021 | August 31, 2024 | DESHAYES, STEPHANIE | reporter.nih.gov |
| Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,545,042 | July 21, 2023 | June 30, 2027 | HOOFNAGLE, ANDREW N | reporter.nih.gov |
| Glucose Management Clinical Decision Support to Improve Outcomes in Academic and Community Hospitals | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,540,544 | December 1, 2021 | November 30, 2026 | PICHARDO-LOWDEN, ARIANA RAQUEL | reporter.nih.gov |
| Evaluating telementoring to initiate a multidimensional diabetes program for Latino(a)s in community clinics: A Randomized Clinical Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,540,455 | September 1, 2021 | July 31, 2027 | VAUGHAN, ELIZABETH M | reporter.nih.gov |
| Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,539,894 | September 17, 2021 | June 30, 2027 | ATKINSON, MARK A. | reporter.nih.gov |
| UroEDIC Bladder: Bladder Dysfunction in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,536,849 | June 1, 2021 | March 31, 2026 | SARMA, ARUNA V | reporter.nih.gov |
| Effects of Fish Oil ± Salsalate on the Omega-3 Index and the Circulating Lipodome of Omega-3 Polyunsaturated Fatty Acid Metabolites in Patients with Type 2 Diabetes and Diabetic Neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,534,893 | February 7, 2022 | January 31, 2027 | YOREK, MARK A. | reporter.nih.gov |
| Sleep and Circadian Regulation in Diabetic Retinopathy: The Role of Intrinsically Photosensitive Retinal Ganglion Cells and Melatonin Supplementation | NIH | National Eye Institute | 2021 to 2024 | $2,534,775 | September 1, 2020 | August 31, 2025 | REUTRAKUL, SIRIMON | reporter.nih.gov |
| The University of Arizona Wound Care Center Clinical Research Unit | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,534,666 | September 15, 2018 | December 31, 2027 | GURTNER, GEOFFREY C | reporter.nih.gov |
| UCLA LIFT-UP (Leveraging Institutional support For Talented, Upcoming Physicians and/or Scientists) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,534,289 | July 15, 2022 | May 31, 2027 | DURU, OBIDIUGWU KENRIK | reporter.nih.gov |
| Impact of environmental toxicants on AD and ADRD risk in the Diabetes Prevention Program Outcomes study AD/ADRD project | NIH | National Institute on Aging | 2024 | $2,533,483 | September 30, 2024 | August 31, 2029 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| Clonal expansion: a marker of disease activity in stage 1 T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,532,731 | July 15, 2024 | June 30, 2027 | LONG, S ALICE | reporter.nih.gov |
| Diabetes, Obesity and Metabolism Training Program | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,531,908 | July 1, 1977 | June 30, 2028 | MORTON, GREGORY J | reporter.nih.gov |
| Metabolic coupling between Schwann cells and axons is functionally distinct from myelination and is disrupted in obesity, prediabetes, and diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,531,361 | August 23, 2022 | June 30, 2027 | FELDMAN, EVA LUCILLE | reporter.nih.gov |
| Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-Age Families | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,528,309 | September 5, 2020 | August 31, 2025 | PATTON, SUSANA R | reporter.nih.gov |
| Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + Secretion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,522,255 | July 15, 2016 | June 30, 2025 | ARVAN, PETER | reporter.nih.gov |
| Engineered Glucose Metabolism in Insulin Secreting Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,521,877 | May 1, 1993 | January 31, 2026 | NEWGARD, CHRISTOPHER B | reporter.nih.gov |
| In vivo and in vitro rare coding variant analyses to identify modulations of the adipocyte differentiation pathway that affect T2D risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,518,891 | July 1, 2020 | March 31, 2026 | FLANNICK, JASON | reporter.nih.gov |
| Host's and microbiota's contribution to sexual dimorphism of autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,515,770 | August 16, 2017 | November 30, 2027 | CHERVONSKY, ALEXANDER V | reporter.nih.gov |
| Managing Obesity by Leveraging Health Information Technology to Lower Cancer Risk | NIH | National Cancer Institute | 2022 to 2025 | $2,511,526 | January 14, 2022 | December 31, 2026 | JOHNSON, KAREN C | reporter.nih.gov |
| Effects of Advanced Glycation Endproducts on Type 2 Diabetic and Fragility Fractures | NIH | National Institute on Aging | 2022 to 2025 | $2,500,180 | August 1, 2022 | April 30, 2027 | VASHISHTH, DEEPAK | reporter.nih.gov |
| Developmental flame retardant exposure, gut microbiome, and obesity | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,499,218 | January 1, 2019 | September 11, 2025 | CUI, JULIA YUE | reporter.nih.gov |
| Notch signaling in diabetic wounds | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,497,010 | May 1, 2021 | April 30, 2026 | GALLAGHER, KATHERINE ANN | reporter.nih.gov |
| Administrative supplement for Intersection of signaling pathways and transcription factors regulating islet development | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,494,396 | July 1, 2018 | December 31, 2027 | GADUE, PAUL J | reporter.nih.gov |
| Defining the role of lymphatic vessels in wound healing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,493,383 | April 1, 2021 | March 31, 2027 | HORSLEY, VALERIE | reporter.nih.gov |
| Role of dynamin-related protein 1 in the regulation of metabolism and skeletal muscle mass | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,491,045 | March 1, 2021 | February 28, 2027 | ZHOU, ZHENQI | reporter.nih.gov |
| LINK-IT: Leveraging vIdeos and commuNity health worKers to Improve diabetes ouTcomes | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $2,490,561 | September 25, 2023 | June 30, 2028 | HU, LU | reporter.nih.gov |
| Multiparametric PET/MRI Assessment of Mast Cell Stabilization Effects on Inflammaging and Glucose Utilization in Infarcted Myocardium | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,488,056 | April 1, 2023 | March 31, 2027 | COKIC, IVAN | reporter.nih.gov |
| Evaluation of the effectiveness of Ajjmuurur Baamḷe DSMES in the RMI | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,486,230 | February 1, 2022 | January 31, 2027 | RIKLON, SHELDON | reporter.nih.gov |
| Role of IRF3 in Energy and Glucose Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,482,473 | April 1, 2015 | August 31, 2025 | ROSEN, EVAN D | reporter.nih.gov |
| Regulation of hippocampal function by central and peripheral IRS signaling | NIH | National Institute on Aging | 2021 to 2024 | $2,480,916 | May 15, 2020 | January 31, 2025 | WHITE, MORRIS F. | reporter.nih.gov |
| Ketone Monitoring Approaches for DKA Risk Mitigation in People with T1D on Adjunctive SGLT2 Inhibitors (KARMA) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,477,577 | September 11, 2025 | August 31, 2028 | PRATLEY, RICHARD E | reporter.nih.gov |
| Cedars Sinai Center for the Chronic Pancreatitis Clinical Research Consortium | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,477,473 | September 28, 2015 | June 30, 2030 | PANDOL, STEPHEN J. | reporter.nih.gov |
| Phthalate Mixture induced Epigenetic Regulations in Adipose Tissues | NIH | National Institute of Environmental Health Sciences | 2025 | $2,472,661 | September 15, 2025 | September 14, 2029 | CHOUDHURY, MAHUA | reporter.nih.gov |
| Human Gut Microbiome and Incident Diabetes Risk in U.S. Populations | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,470,030 | January 19, 2021 | December 31, 2025 | SUN, QI | reporter.nih.gov |
| Gut microbial fermentation products of muscle-derived lactate as mediators of exercise and metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,469,326 | April 1, 2022 | March 31, 2027 | KOSTIC, ALEKSANDAR DAVID | reporter.nih.gov |
| New way in delivering immunomodulatory drugs in T1D | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,465,695 | February 17, 2022 | January 31, 2026 | ABDI, REZA | reporter.nih.gov |
| MiR-409-3p Regulates Angiogensis, Brown Fat Adiposity and Insulin Resistance | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,460,011 | June 1, 2021 | May 31, 2026 | ICLI, BASAK | reporter.nih.gov |
| High-resolution, virome-wide infection analysis in type 1 diabetes birth cohorts | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,459,418 | June 1, 2024 | May 31, 2027 | ALTIN, JOHN | reporter.nih.gov |
| Testing a very low-carbohydrate diet version of the Diabetes Prevention Program to reduce risk factors for type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,458,834 | August 15, 2021 | April 30, 2027 | SASLOW, LAURA | reporter.nih.gov |
| Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,455,882 | July 1, 2020 | March 31, 2026 | SCHMIDT, ANN MARIE | reporter.nih.gov |
| Environmental and Social Exposure Factors, Epigenetics, and Metabolic Health in Puerto Rican Adults | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,454,594 | September 21, 2022 | November 30, 2027 | ORDOVAS, JOSE M. | reporter.nih.gov |
| Behavioral Nudges for Diabetes Prevention (BEGIN) Trial in Primary Care | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,450,684 | September 15, 2020 | June 30, 2025 | O'BRIEN, MATTHEW JAMES | reporter.nih.gov |
| Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,447,499 | July 27, 2022 | June 30, 2027 | NADEAU, KRISTEN JANE | reporter.nih.gov |
| Transcriptional and epigenetic regulation of thermogenic adipocyte program | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,447,256 | April 6, 2022 | March 31, 2027 | TSENG, YU-HUA | reporter.nih.gov |
| Mechanisms regulating VEGF receptors in diabetic angiogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,443,536 | January 1, 2016 | June 30, 2025 | CHEN, HONG | reporter.nih.gov |
| Humanized Mouse Avatars for T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,439,759 | September 25, 2014 | May 31, 2024 | GREINER, DALE LESLIE | reporter.nih.gov |
| Technology-Supported Treatment of Sleep Apnea in Prediabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,438,959 | August 1, 2019 | July 31, 2025 | TASALI, ESRA | reporter.nih.gov |
| Non-Standard Protein Design in Molecular Endocrinology: Insulin and Glucagon | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,434,606 | August 1, 1989 | June 30, 2025 | WEISS, MICHAEL AARON | reporter.nih.gov |
| Targeted Genetic Analysis of T2D and Quantitative Traits | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,433,700 | September 1, 2005 | July 31, 2025 | MOHLKE, KAREN L. | reporter.nih.gov |
| Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,428,878 | September 12, 2022 | May 31, 2026 | RAFII, SHAHIN | reporter.nih.gov |
| Immunomodulatory Therapy for Neuropathic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,420,195 | September 1, 2018 | August 31, 2025 | CHEN, RIDONG | reporter.nih.gov |
| Glycosyltransferase Function in Development and Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,418,000 | September 15, 1994 | March 31, 2027 | MARTH, JAMEY | reporter.nih.gov |
| Artificial Pancreas - Adolescent Physiology and Psychology Longitudinal Evaluation (A.P. APPLE) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,415,579 | April 1, 2020 | March 31, 2026 | DEBOER, MARK DANIEL | reporter.nih.gov |
| Integration of Feeding Time and Glucose Metabolism by the Circadian Gene Network | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,412,877 | September 17, 2021 | June 30, 2027 | BASS, JOSEPH | reporter.nih.gov |
| Virome and Immune Responses associated with IA and Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,412,388 | March 5, 2024 | January 31, 2027 | LLOYD, RICHARD E | reporter.nih.gov |
| The role of circulating meta-inflammatory monocytes in adolescent insulin resistance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,411,942 | August 1, 2022 | May 31, 2027 | SINGER, KANAKADURGA | reporter.nih.gov |
| Redox-sensitive activation of REDD1 in diabetic retinopathy | NIH | National Eye Institute | 2021 to 2025 | $2,408,855 | September 30, 2021 | July 31, 2028 | DENNIS, MICHAEL D | reporter.nih.gov |
| Glucose instability and neurocognitive outcomes in older adults | NIH | National Institute on Aging | 2021 | $2,408,159 | September 30, 2021 | August 31, 2025 | SELVIN, ELIZABETH | reporter.nih.gov |
| Autophagy and its Regulation in Diabetic Embryopathy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,402,214 | May 7, 2014 | February 28, 2026 | YANG, PEIXIN | reporter.nih.gov |
| Identifying Genes for Type 2 Diabetes: FUSION | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,399,903 | July 1, 2002 | December 31, 2026 | BOEHNKE, MICHAEL L | reporter.nih.gov |
| Glycemic reduction approaches in polycystic ovary syndrome: a comparative effectiveness study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,399,124 | December 15, 2021 | November 30, 2026 | SASLOW, LAURA | reporter.nih.gov |
| Continuation of The Collaborative Islet Transplantation Registry (CITR) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,399,074 | September 15, 2022 | June 30, 2027 | PAYNE, ELIZABETH HOLLY | reporter.nih.gov |
| Leveraging early-life microbes to prevent type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,398,489 | April 1, 2023 | February 29, 2028 | SILVERMAN, MICHAEL A | reporter.nih.gov |
| TOPMed Omics of Cardiovascular Disease in Diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,397,368 | July 1, 2020 | June 30, 2025 | MEIGS, JAMES B | reporter.nih.gov |
| Effect of temporal distribution of macronutrient intake on metabolism | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,396,595 | July 10, 2023 | June 30, 2028 | SCHEER, FRANK A | reporter.nih.gov |
| Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohort | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,395,247 | May 23, 2022 | March 31, 2027 | DE BOER, IAN H | reporter.nih.gov |
| Neural control of pancreatic endocrine function in obesity and diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,392,222 | January 6, 2021 | December 31, 2025 | STANLEY, SARAH AMY | reporter.nih.gov |
| Scalable and transplantable pancreatic islet organoids with engineered oxygenation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,390,830 | September 1, 2025 | August 31, 2029 | KOMATSU, HIROTAKE | reporter.nih.gov |
| Does insulin sensitivity impact the potential of metformin to slow aging? | NIH | National Institute on Aging | 2021 to 2024 | $2,389,499 | September 1, 2019 | February 28, 2026 | MILLER, BENJAMIN FRANCIS | reporter.nih.gov |
| Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,389,239 | July 15, 2023 | June 30, 2027 | OWENS, GARY K | reporter.nih.gov |
| Histone H3 O-GlcNAcylation in Endothelial Cells Promotes Diabetic Vascular Complications | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,381,683 | September 7, 2025 | August 31, 2029 | HE, MING | reporter.nih.gov |
| Type 2 Diabetes Mellitus and Vascular Contributions to Cognitive Impairment and Dementia (T2DM-VCID) | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,380,018 | September 18, 2024 | August 31, 2027 | LEVINE, DEBORAH ALLISON | reporter.nih.gov |
| Second generation GLP-1 agonists without nausea/emesis side effects | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,378,157 | March 1, 2021 | February 28, 2026 | HAYES, MATTHEW R | reporter.nih.gov |
| Strengths-Based Multi-Level Behavioral Intervention to Promote Resilience and Self-Management in Youth with Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,369,928 | July 20, 2022 | May 31, 2028 | HILLIARD, MARISA ELLEN | reporter.nih.gov |
| Role of Circadian Misalignment in Beta-cell Failure in Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,369,178 | July 1, 2013 | June 30, 2027 | MATVEYENKO, ALEKSEY V | reporter.nih.gov |
| Regulation of pancreatic islet cell fate | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,361,366 | August 1, 2009 | July 31, 2027 | SUSSEL, LORI | reporter.nih.gov |
| Effect of Dietary Carbohydrate on Diabetes Control and Beta Cell Function in Children with Newly Diagnosed Diabetes.” | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,359,048 | May 1, 2023 | April 30, 2029 | LENNERZ, BELINDA S | reporter.nih.gov |
| Lipid Antigen Presentation as a Driver of T2D Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,358,570 | August 18, 2022 | July 31, 2027 | NICHOLAS, DEQUINA ANGELINA | reporter.nih.gov |
| Randomized Controlled Trial of a Six-Month Mindfulness-Based Intervention for Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,357,044 | April 15, 2019 | December 31, 2025 | RAJA-KHAN, NAZIA T. | reporter.nih.gov |
| A Targeted Self-Management Intervention for Reducing Stroke Risk Factors in High Risk Ugandans | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,356,262 | September 1, 2020 | June 30, 2026 | SAJATOVIC, MARTHA X | reporter.nih.gov |
| Mitigating Diabetic Ketoacidosis in People with T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation into an Enhanced Glucose Ketone Report | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,352,906 | September 1, 2025 | August 31, 2028 | BERGENSTAL, RICHARD MAURITZ | reporter.nih.gov |
| Understanding the variation of induced β-cell differentiation. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,351,360 | July 1, 2022 | June 30, 2027 | LI, YAN | reporter.nih.gov |
| Keeping fat out of muscle - Role of Branched Amino AcidsAmino Acids in Insulin Resistance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,349,410 | July 1, 2018 | August 31, 2027 | ARANY, ZOLTAN P | reporter.nih.gov |
| Thinking Outside the Clinic: A Digital Health Approach for Young Adults with Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,345,203 | April 1, 2020 | March 31, 2026 | CATHERINE STANGER, CATHERINE STANGER CATHERINE STANGER | reporter.nih.gov |
| Care partner-assisted ImplementatiOn of Patch HybrId Closed Loop Insulin Delivery for Older Adults with T1D (COPILOT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,345,176 | September 3, 2025 | August 31, 2028 | HENDERSON, ROBERT J | reporter.nih.gov |
| Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,344,037 | September 10, 2013 | December 31, 2029 | BAUR, JOSEPH A. | reporter.nih.gov |
| Islet-specific CD8 T cells in the pathogenesis of type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,344,031 | August 20, 2013 | May 31, 2030 | NAKAYAMA, MAKI | reporter.nih.gov |
| Cross-regulation of Immunometabolism and Circadian Pathways in Obesity Pathophysiology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,341,977 | April 15, 2021 | March 31, 2027 | BASS, JOSEPH | reporter.nih.gov |
| Measurement error correction approaches to wearable device-based measures of physical activity and self-reported measures of dietary intake in obesity and type 2 diabetes research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,341,644 | April 15, 2022 | February 28, 2027 | TEKWE, CARMEN D. | reporter.nih.gov |
| PP2A as a drug target for diabetic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,334,369 | July 21, 2020 | April 30, 2025 | HE, JOHN CIJIANG | reporter.nih.gov |
| Durable Schistosome induced metabolic alterations to the myeloid lineage | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,333,788 | March 5, 2021 | February 28, 2026 | FAIRFAX, KEKE CELESTE | reporter.nih.gov |
| Power-Up: An Effectiveness Trial of the Diabetes Prevention Program Tailored for Black and Latino Men | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,332,727 | September 16, 2019 | August 31, 2025 | CHAMBERS, EARLE C | reporter.nih.gov |
| Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,332,346 | September 15, 2020 | December 31, 2022 | TSE, HUBERT M | reporter.nih.gov |
| Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,328,420 | September 20, 2019 | May 31, 2024 | SYKES, MEGAN | reporter.nih.gov |
| Sleep optimization to improve glycemic control in adults with type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,328,270 | July 1, 2020 | April 30, 2026 | MARTYN-NEMETH, PAMELA ANN | reporter.nih.gov |
| The KQ1 serum study: soluble biomarkers for T1D risk, development & progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,326,300 | February 1, 2024 | January 31, 2026 | HOMANN, DIRK | reporter.nih.gov |
| Identifying lifelong factors that impact brain health and outcomes in type 1 diabetes: The Cognition and Longitudinal Assessments of Risk Factors over 30 Years (CLARiFY) Diabetes Complications Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,325,031 | September 1, 2021 | July 31, 2026 | FELDMAN, EVA LUCILLE | reporter.nih.gov |
| Role of Extracellular Vesicle: Autophagy Pathway Crosstalk in Type 2 Diabetes Pathogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,325,005 | September 4, 2025 | August 31, 2029 | JAVEED, NAUREEN | reporter.nih.gov |
| Transcriptional and Translational Mechanisms Governing Beta Cell Function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,322,333 | March 1, 2002 | April 30, 2027 | MIRMIRA, RAGHAVENDRA G | reporter.nih.gov |
| Targeting LRRC8 signaling to prevent & treat arterial thrombosis in type 2 diabetes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,320,705 | September 1, 2023 | August 31, 2026 | LERNER, DANIEL J | reporter.nih.gov |
| Multi-Omics at the Intersections of Environment, Diabetes, and Kidney Disease: A Multi-Omics for Health and Disease Study Site | NIH | National Human Genome Research Institute | 2023 to 2025 | $2,316,134 | September 12, 2023 | May 31, 2028 | KELLY, TANIKA NICOLE | reporter.nih.gov |
| DYSBIOTIC MICROBIOME IN PANCREATITIS, DIABETES, AND PANCREATIC CANCER | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,315,838 | September 28, 2015 | June 30, 2025 | FISHER, WILLIAM E | reporter.nih.gov |
| Mechanisms of Prediabetic States in Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,314,671 | July 15, 2019 | June 30, 2025 | TASALI, ESRA | reporter.nih.gov |
| Derivation of pancreatic islet-like organoids from human gastric stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,313,256 | August 24, 2022 | May 31, 2026 | RAFII, SHAHIN | reporter.nih.gov |
| Enhancing the Diabetes Prevention Program to promote weight loss among non-responders in a community based lifestyle intervention | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,312,165 | July 15, 2020 | June 30, 2026 | WILLIAMS, LOVORIA B | reporter.nih.gov |
| Adipose Tissue Metabolic Stress Responses | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,301,652 | July 17, 2017 | June 30, 2026 | DAVIS, ROGER J. | reporter.nih.gov |
| Analysis of Lipolytic Trafficking in Adipocytes. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,301,401 | June 1, 2009 | March 31, 2027 | GRANNEMAN, JAMES G | reporter.nih.gov |
| Biomarkers of Habitual Short Sleep and Related Cardiometabolic Risk | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,300,389 | June 1, 2023 | May 31, 2025 | DEPNER, CHRISTOPHER MICHAEL | reporter.nih.gov |
| Improving Proinsulin Folding to Ameliorate Type II Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,300,175 | May 5, 2023 | April 30, 2027 | KAUFMAN, RANDAL J. | reporter.nih.gov |
| TLC-1235, a controlled-release mitochondrial protonophore (CRMP), for the reversal of insulin resistance in patients with severe lipodystrophy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $2,299,997 | September 22, 2022 | August 31, 2025 | MYERS, ROBERT PAUL | reporter.nih.gov |
| The impact of insulin sensitivity on the potential of metformin to delay age-related inflammation | NIH | National Institute on Aging | 2022 to 2025 | $2,299,749 | August 15, 2022 | April 30, 2027 | NIKOLAJCZYK, BARBARA | reporter.nih.gov |
| Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,299,513 | April 1, 2022 | March 31, 2027 | MIAO, QING | reporter.nih.gov |
| The B Cell Insulin Receptor in Health and in Insulin Resistance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,299,235 | December 15, 2021 | November 30, 2026 | WINER, DAN | reporter.nih.gov |
| Anti-hIAPP for the preservation of pancreatic function in Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $2,299,156 | September 22, 2022 | January 31, 2026 | MURAD, JOANA M | reporter.nih.gov |
| Glucose homeostasis and the risk of Alzheimer's disease and Alzheimer's disease related dementias in the Multi-Ethnic Study of Atherosclerosis | NIH | National Institute on Aging | 2021 | $2,295,981 | September 30, 2021 | August 31, 2024 | MONGRAW-CHAFFIN, MORGANA LEE | reporter.nih.gov |
| Epitranscriptomic Alteration and Planar Cell Polarity Signaling In Diabetic Embroyopathy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,294,873 | September 21, 2020 | July 31, 2025 | REECE, E. ALBERT | reporter.nih.gov |
| Engineering optimization and scaling enables high quality pancreatic islet cryopreservation for banking and transplant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,294,596 | September 22, 2021 | July 31, 2025 | FINGER, ERIK BRIAN | reporter.nih.gov |
| Thymic selection abnormalities in Type 1 Diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,291,187 | June 26, 2023 | May 31, 2028 | SYKES, MEGAN | reporter.nih.gov |
| Targeted delivery of a proangiogenic and promyogenic protein for regeneration of diabetic ischemic limbs | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,288,622 | May 2, 2022 | April 30, 2027 | GUAN, JIANJUN | reporter.nih.gov |
| Coupling of vascular CaV1.2 channels in health and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,286,262 | July 1, 2015 | April 30, 2026 | NAVEDO, MANUEL F | reporter.nih.gov |
| Biochemical Mechanism of Beta-Cell Destruction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,284,193 | June 1, 2022 | March 31, 2027 | CORBETT, JOHN A | reporter.nih.gov |
| Morning Meal-Associated Priming of the Liver | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,282,667 | September 24, 2021 | July 31, 2025 | CHERRINGTON, ALAN D | reporter.nih.gov |
| Diabetes in African Youth: Improving Glucose Time-In-Range | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,281,071 | April 1, 2022 | March 31, 2027 | MORAN, ANTOINETTE M. | reporter.nih.gov |
| Improving physical function and quality of life in older adults with prediabetes utilizing interactive small-group resistance training through video conference technology | NIH | National Institute on Aging | 2022 to 2024 | $2,279,549 | April 15, 2022 | August 31, 2025 | LEVITAN, ERIC | reporter.nih.gov |
| Contribution of immune modulation, metabolism, and microbiota to Group B Streptococcal urinary tract infection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,277,552 | September 21, 2021 | June 30, 2027 | PATRAS, KATY | reporter.nih.gov |
| Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,276,928 | April 15, 2021 | February 28, 2027 | SHEFFIELD, VAL C. | reporter.nih.gov |
| A low cost and effective foot orthotics fabrication framework | NIH | National Institute on Aging | 2021 to 2024 | $2,276,550 | June 1, 2021 | May 31, 2026 | YI, STEVEN | reporter.nih.gov |
| Effects of GLP-l receptor agonists on cardiometabolic alterations in HIV-associated lipohypertrophy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,275,324 | April 10, 2019 | March 31, 2025 | MCCOMSEY, GRACE A | reporter.nih.gov |
| Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes | NIH | National Cancer Institute | 2023 to 2025 | $2,274,110 | July 1, 2023 | June 30, 2028 | FREEDLAND, STEPHEN JAY | reporter.nih.gov |
| Mechanism of Renal Cortical Insulin Resistance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,268,289 | September 1, 2022 | April 30, 2026 | SHULMAN, GERALD I | reporter.nih.gov |
| Reducing innate inflammation in new onset T1D with Lactobacillus plantarum | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,267,995 | August 21, 2020 | May 31, 2026 | HESSNER, MARTIN J | reporter.nih.gov |
| Clinical and Nutrigenetic Assessment of Zinc in Patients with Prediabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,266,848 | August 15, 2023 | May 31, 2028 | LEWIS, JOSHUA PATRICK | reporter.nih.gov |
| Maternal Obesity, Milk Composition, and Infant Growth | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,265,508 | July 10, 2014 | February 28, 2026 | DEMERATH, ELLEN W. | reporter.nih.gov |
| Alternative polyadenylation as a novel mechanism for diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,265,447 | August 28, 2023 | May 31, 2027 | YANG, QIN | reporter.nih.gov |
| Determining the Intrinsic and Environmental Signal Contributing to Early T1D Progression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,260,661 | September 15, 2020 | June 30, 2025 | CHEN, SHUIBING | reporter.nih.gov |
| Mechanism of ultrasound neuromodulation effects on glucose homeostasis and diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,260,452 | February 1, 2023 | January 31, 2028 | HERZOG, RAIMUND INGO | reporter.nih.gov |
| Clinical Research and Epidemiology in Diabetes and Endocrinology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,258,898 | September 30, 2002 | June 30, 2028 | BROWN, TODD T | reporter.nih.gov |
| Fibroblast Growth Factor and Energy Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,257,939 | July 3, 2015 | March 31, 2026 | TSENG, YU-HUA | reporter.nih.gov |
| Utilizing continuous ketone monitors to enable safe use of SGLT inhibitors in patients with Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,257,919 | September 11, 2025 | August 31, 2028 | PETTUS, JEREMY H | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Benaroya Research Inst at Virginia Mason | Seattle, WA | 9 | $221.6 million | 0 | $0 |
| University of South Florida | Tampa, FL | 15 | $201.2 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 58 | $151.7 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 124 | $145.7 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 69 | $127.1 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 78 | $108.5 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 116 | $106.2 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 60 | $97.7 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 57 | $94.4 million | 0 | $0 |
| Yale University | New Haven, CT | 80 | $93.7 million | 0 | $0 |
| Stanford University | Stanford, CA | 68 | $87.8 million | 0 | $0 |
| University of Washington | Seattle, WA | 39 | $85.1 million | 0 | $0 |
| Joslin Diabetes Center | Boston, MA | 50 | $84.9 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 70 | $81.5 million | 0 | $0 |
| Washington University | Saint Louis, MO | 69 | $75.5 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 55 | $70.2 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 23 | $66.4 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 37 | $61.9 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 59 | $61.9 million | 0 | $0 |
| University of Chicago | Chicago, IL | 34 | $61.3 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 48 | $59.8 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 47 | $57.9 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 61 | $57.7 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 44 | $57.5 million | 0 | $0 |
| University of Florida | Gainesville, FL | 49 | $54.8 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 57 | $52.6 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 37 | $51.8 million | 0 | $0 |
| Jaeb Center for Health Research, Inc. | Tampa, FL | 4 | $51.5 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 30 | $50.8 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 32 | $49.4 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 49 | $49.3 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 20 | $47.5 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 44 | $47.4 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 36 | $46.6 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 38 | $46.5 million | 0 | $0 |
| Emory University | Atlanta, GA | 41 | $45.5 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 32 | $44.6 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 31 | $43.5 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 30 | $42.4 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 38 | $42 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 17 | $41 million | 0 | $0 |
| University of California at Davis | Davis, CA | 29 | $40.6 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 33 | $39.8 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 24 | $39.1 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 34 | $38.9 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 35 | $37.5 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 27 | $37.5 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 47 | $37.1 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 26 | $36.6 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 33 | $36.3 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 40 | $36 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 27 | $33.9 million | 0 | $0 |
| Children's Hospital of Los Angeles | Los Angeles, CA | 8 | $32.9 million | 0 | $0 |
| George Washington University | Washington, DC | 12 | $32.7 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 27 | $32.2 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 40 | $31.9 million | 0 | $0 |
| Duke University | Durham, NC | 33 | $31.5 million | 0 | $0 |
| Wayne State University | Detroit, MI | 30 | $31.3 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 26 | $30.3 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 25 | $30.1 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 22 | $30 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 23 | $29.5 million | 0 | $0 |
| Rho Federal Systems Division, Inc. | Durham, NC | 1 | $28.4 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 19 | $26.6 million | 0 | $0 |
| Avera Mckennan | Sioux Falls, SD | 2 | $26.5 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 21 | $23.9 million | 0 | $0 |
| Oklahoma Medical Research Foundation | Oklahoma City, OK | 4 | $21.2 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 14 | $20.3 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 10 | $20.2 million | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 9 | $19 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 17 | $19 million | 0 | $0 |
| Ohio State University | Columbus, OH | 19 | $18.9 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 16 | $18.2 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 16 | $17.9 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 13 | $17.8 million | 0 | $0 |
| LSU Pennington Biomedical Research CTR | Baton Rouge, LA | 19 | $16 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 17 | $15.6 million | 0 | $0 |
| University of Hawaii | Honolulu, HI | 6 | $14.9 million | 0 | $0 |
| University of Tennessee Health Sci CTR | Memphis, TN | 11 | $14.5 million | 0 | $0 |
| Univ of Arkansas for Med Scis | Little Rock, AR | 7 | $14.2 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 15 | $14 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 9 | $13.9 million | 0 | $0 |
| Rockefeller University | New York, NY | 4 | $12.6 million | 0 | $0 |
| Augusta University | Augusta, GA | 17 | $11.9 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 5 | $11.8 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 12 | $11.8 million | 0 | $0 |
| University of Oklahoma HLTH Sciences CTR | Oklahoma City, OK | 17 | $11.8 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 12 | $11.5 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 9 | $11.5 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 10 | $11.4 million | 0 | $0 |
| Florida State University | Tallahassee, FL | 8 | $11.3 million | 0 | $0 |
| Colorado State University | Fort Collins, CO | 10 | $10.7 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 4 | $10 million | 0 | $0 |
| Tufts Medical Center | Boston, MA | 7 | $9.9 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 13 | $9.9 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 14 | $9.8 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 9 | $9.8 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 9 | $9.8 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 12 | $9 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 6 | $8.9 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 1,601 | $1,036,353,094 | 0 | $0 |
| 2024 | 1,828 | $1,025,988,112 | 0 | $0 |
| 2023 | 1,897 | $1,061,469,455 | 0 | $0 |
| 2022 | 1,946 | $1,050,041,149 | 0 | $0 |
| 2021 | 1,976 | $1,027,212,647 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.